Clinical trial NCT01126437: Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
Official title: A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Pulmonary Disease, Chronic Obstructive
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2010-05-19
Enrollment: 17183
Sex: ALL
Minimum age (years): 40
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Direct comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies. Therefore, prospective data from a trial of adequate size and duration is required to establish that compared to tiotropium HandiHaler®, tiotropium Respimat® will have (a) similar effects on safety and (b) similar or superior effects on exacerbations.


Eligibility criteria: Inclusion criteria:

1. All patients must sign an informed consent consistent with International Conference on Harmonization Good Clinical Practice (ICH-GCP) guidelines prior to participation in the trial, which includes medication washout and restrictions.
2. Male or female patients 40 years of age or older.
3. Patients must be current or ex-smokers with a smoking history of ≥10 pack-years. (Patients who have never smoked cigarettes must be excluded)
4. All patients must have a diagnosis of COPD (P06-12085), and must meet the following criteria: Relatively stable airway obstruction with a post-bronchodilator FEV1 ≤ 70% of predicted normal and post-bronchodilator FEV1 / FVC ≤70%.

   Pulmonary function tests (PFTs) were conducted after the inhalation of 400 μg salbutamol / albuterol (preferred), however testing with either 200 μg salbutamol/albuterol or a combination of salbutamol / albuterol with ipratropium bromide (2 to 4 actuations) was acceptable. Other short-acting beta agonists, such as terbutaline, may have been used for the testing. The medication used for the testing was documented. Further, historical data from measurements within the past 6 months either at the site or at a referral site may have been used (see Section 6.2.1 of the CTP, located in Appendix 16.1.1). Subjects were not to have been randomized to the study without the availability of spirometry data at the actual study site.

   Eligibility for PFT sub-study: For subjects participating in the spirometry sub-study, historical data may not have been used for inclusion. These subjects must have qualified in the clinic at Visit 1 after performing a baseline measurement. These subjects performed a pre-dose PFT which was followed by the administration of 400 μg salbutamol / albuterol only (no other short-acting beta agonist was allowed), followed by a post-dose PFT for qualification.
5. Able to inhale from the HandiHaler® and the Respimat® devices.

Exclusion criteria:

1. Significant diseases other than COPD. A significant disease is defined as a disease or condition which, in the opinion of the investigator, may put the patient at risk because of participation in the study or may influence the patients ability to participate in the study.
2. Patients with a recent history (i.e., six months or less) of myocardial infarction.
3. Patients with any unstable or life-threatening cardiac arrhythmia requiring intervention or change in drug therapy during the last year.
4. Hospitalisation for cardiac failure (New York Heart Association (NYHA) Class III or IV) during the past year.
5. Known active tuberculosis.
6. Patients with a history of asthma, cystic fibrosis, clinically evident bronchiectasis, interstitial lung disease, or pulmonary thromboembolic disease.
7. History of thoracotomy with pulmonary resection. Subjects with a history of thoracotomy for other reasons were to have been evaluated per exclusion criterion 1.
8. Subject was planning to undergo lung transplant or lung volume reduction surgery (LVRS).
9. Malignancy for which the subject had undergone resection, radiation, chemotherapy or biological treatments within the last 5 years. Subjects with treated basal cell carcinoma were allowed.
10. Known respiratory infection or exacerbation of COPD in the 4 weeks prior to randomization.
11. Known hypersensitivity to anticholinergic drugs, lactose, benzalkonium chloride (BAC), ethylenediaminetetraacetic acid (EDTA), or any other components of the HandiHaler® or Respimat® inhalation solution delivery system.
12. Known moderate to severe renal impairment (as judged by the investigator).
13. Known narrow angle glaucoma.
14. Known significant symptomatic prostatic hyperplasia or bladder-neck obstruction. Subjects whose symptoms were controlled on treatment may have been included.
15. Use of systemic corticosteroid medication at unstable doses (i.e., less than 6 weeks on stable dose) or at doses in excess of the equivalent of 10 mg prednisolone per day.
16. Pregnant or nursing women or women of childbearing potential not using a medically approved means of contraception for at least 3 months prior to and for the duration of the trial.
17. Significant alcohol or drug abuse within the past 12 months.
18. Subjects requiring the use of supplemental oxygen therapy for \> 12 hours per day.
19. Subjects who had completed a pulmonary rehabilitation program in the 6 weeks prior to the screening visit or subjects who were currently in a pulmonary rehabilitation program that was not maintained throughout the duration of the study.
20. Subjects who had taken an investigational drug within 30 days prior to the Screening Visit.
21. Previous participation (receipt of randomized treatment) in this study.
22. Subjects who were currently participating in an interventional study.

Primary outcomes:
measure: Time to All-Cause Mortality
timeFrame: Up to 3 years
measure: Time to First COPD Exacerbation
timeFrame: Up to 3 years
Secondary outcomes:
measure: Trough FEV1 Over 120 Weeks (in a Substudy of 1370 Patients)
timeFrame: Up to 3 years
measure: Number of COPD Exacerbations
timeFrame: Up to 3 years
measure: Time to First Hospitalization Associated With COPD Exacerbation
timeFrame: Up to 3 years
measure: Number of Hospitalizations Associated With COPD Exacerbation
timeFrame: Up to 3 years
measure: Time to First Moderate to Severe COPD Exacerbation
timeFrame: Up to 3 years
measure: Time to Onset of First Major Adverse Cardiovascular Event (MACE)
timeFrame: Up to 3 years
measure: Time to Death From Major Adverse Cardiovascular Event (MACE)
timeFrame: Up to 3 years
Other outcomes:
Locations:
city: Athens
country: United States
facility: 205.452.01107 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 205.452.01023 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 205.452.01035 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 205.452.01052 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 205.452.01219 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 205.452.01227 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 205.452.01280 Boehringer Ingelheim Investigational Site
state: Alabama
city: Florence
country: United States
facility: 205.452.01198 Boehringer Ingelheim Investigational Site
state: Alabama
city: Mobile
country: United States
facility: 205.452.01244 Boehringer Ingelheim Investigational Site
state: Alabama
city: Montgomery
country: United States
facility: 205.452.01041 Boehringer Ingelheim Investigational Site
state: Alabama
city: Anchorage
country: United States
facility: 205.452.01070 Boehringer Ingelheim Investigational Site
state: Alaska
city: Chandler
country: United States
facility: 205.452.01218 Boehringer Ingelheim Investigational Site
state: Arizona
city: Mesa
country: United States
facility: 205.452.01175 Boehringer Ingelheim Investigational Site
state: Arizona
city: Mesa
country: United States
facility: 205.452.01200 Boehringer Ingelheim Investigational Site
state: Arizona
city: Mesa
country: United States
facility: 205.452.01317 Boehringer Ingelheim Investigational Site
state: Arizona
city: Pheonix
country: United States
facility: 205.452.01350 Boehringer Ingelheim Investigational Site
state: Arizona
city: Phoenix
country: United States
facility: 205.452.01254 Boehringer Ingelheim Investigational Site
state: Arizona
city: Phoenix
country: United States
facility: 205.452.01283 Boehringer Ingelheim Investigational Site
state: Arizona
city: Tempe
country: United States
facility: 205.452.01315 Boehringer Ingelheim Investigational Site
state: Arizona
city: Tucson
country: United States
facility: 205.452.01158 Boehringer Ingelheim Investigational Site
state: Arizona
city: Tucson
country: United States
facility: 205.452.01161 Boehringer Ingelheim Investigational Site
state: Arizona
city: Anaheim
country: United States
facility: 205.452.01302 Boehringer Ingelheim Investigational Site
state: California
city: Encinitas
country: United States
facility: 205.452.01038 Boehringer Ingelheim Investigational Site
state: California
city: Fountain Valley
country: United States
facility: 205.452.01313 Boehringer Ingelheim Investigational Site
state: California
city: Fountain Valley
country: United States
facility: 205.452.01375 Boehringer Ingelheim Investigational Site
state: California
city: Fullerton
country: United States
facility: 205.452.01074 Boehringer Ingelheim Investigational Site
state: California
city: Lancaster
country: United States
facility: 205.452.01345 Boehringer Ingelheim Investigational Site
state: California
city: Lincoln
country: United States
facility: 205.452.01171 Boehringer Ingelheim Investigational Site
state: California
city: Lomita
country: United States
facility: 205.452.01339 Boehringer Ingelheim Investigational Site
state: California
city: Los Angeles
country: United States
facility: 205.452.01298 Boehringer Ingelheim Investigational Site
state: California
city: Los Angeles
country: United States
facility: 205.452.01356 Boehringer Ingelheim Investigational Site
state: California
city: Orange
country: United States
facility: 205.452.01148 Boehringer Ingelheim Investigational Site
state: California
city: Palm Springs
country: United States
facility: 205.452.01111 Boehringer Ingelheim Investigational Site
state: California
city: Paramount
country: United States
facility: 205.452.01147 Boehringer Ingelheim Investigational Site
state: California
city: Poway
country: United States
facility: 205.452.01071 Boehringer Ingelheim Investigational Site
state: California
city: Rancho Cucamonga
country: United States
facility: 205.452.01089 Boehringer Ingelheim Investigational Site
state: California
city: Redlands
country: United States
facility: 205.452.01097 Boehringer Ingelheim Investigational Site
state: California
city: San Diego
country: United States
facility: 205.452.01078 Boehringer Ingelheim Investigational Site
state: California
city: San Diego
country: United States
facility: 205.452.01176 Boehringer Ingelheim Investigational Site
state: California
city: San Diego
country: United States
facility: 205.452.01346 Boehringer Ingelheim Investigational Site
state: California
city: San Jose
country: United States
facility: 205.452.01306 Boehringer Ingelheim Investigational Site
state: California
city: Santa Barbara
country: United States
facility: 205.452.01297 Boehringer Ingelheim Investigational Site
state: California
city: Tustin
country: United States
facility: 205.452.01362 Boehringer Ingelheim Investigational Site
state: California
city: Victorville
country: United States
facility: 205.452.01225 Boehringer Ingelheim Investigational Site
state: California
city: Walnut Creek
country: United States
facility: 205.452.01224 Boehringer Ingelheim Investigational Site
state: California
city: Wildomar
country: United States
facility: 205.452.01236 Boehringer Ingelheim Investigational Site
state: California
city: Colorado Springs
country: United States
facility: 205.452.01049 Boehringer Ingelheim Investigational Site
state: Colorado
city: Colorado Springs
country: United States
facility: 205.452.01245 Boehringer Ingelheim Investigational Site
state: Colorado
city: Denver
country: United States
facility: 205.452.01351 Boehringer Ingelheim Investigational Site
state: Colorado
city: Fort Collins
country: United States
facility: 205.452.01018 Boehringer Ingelheim Investigational Site
state: Colorado
city: Wheat Ridge
country: United States
facility: 205.452.01005 Boehringer Ingelheim Investigational Site
state: Colorado
city: Wheat Ridge
country: United States
facility: 205.452.01024 Boehringer Ingelheim Investigational Site
state: Colorado
city: Danbury
country: United States
facility: 205.452.01199 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Hartford
country: United States
facility: 205.452.01054 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Norwalk
country: United States
facility: 205.452.01072 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Stamford
country: United States
facility: 205.452.01040 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Waterbury
country: United States
facility: 205.452.01109 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Newark
country: United States
facility: 205.452.01308 Boehringer Ingelheim Investigational Site
state: Delaware
city: Clearwater
country: United States
facility: 205.452.01011 Boehringer Ingelheim Investigational Site
state: Florida
city: Hialeah
country: United States
facility: 205.452.01209 Boehringer Ingelheim Investigational Site
state: Florida
city: Homestead
country: United States
facility: 205.452.01360 Boehringer Ingelheim Investigational Site
state: Florida
city: Jacksonville
country: United States
facility: 205.452.01241 Boehringer Ingelheim Investigational Site
state: Florida
city: Jacksonville
country: United States
facility: 205.452.01337 Boehringer Ingelheim Investigational Site
state: Florida
city: Jacksonville
country: United States
facility: 205.452.01343 Boehringer Ingelheim Investigational Site
state: Florida
city: Jupiter
country: United States
facility: 205.452.01184 Boehringer Ingelheim Investigational Site
state: Florida
city: Miami
country: United States
facility: 205.452.01138 Boehringer Ingelheim Investigational Site
state: Florida
city: Miami
country: United States
facility: 205.452.01246 Boehringer Ingelheim Investigational Site
state: Florida
city: Miami
country: United States
facility: 205.452.01321 Boehringer Ingelheim Investigational Site
state: Florida
city: New Port Richey
country: United States
facility: 205.452.01290 Boehringer Ingelheim Investigational Site
state: Florida
city: Ocala
country: United States
facility: 205.452.01203 Boehringer Ingelheim Investigational Site
state: Florida
city: Orlando
country: United States
facility: 205.452.01174 Boehringer Ingelheim Investigational Site
state: Florida
city: Ormond Beach
country: United States
facility: 205.452.01135 Boehringer Ingelheim Investigational Site
state: Florida
city: Oviedo
country: United States
facility: 205.452.01173 Boehringer Ingelheim Investigational Site
state: Florida
city: Panama City
country: United States
facility: 205.452.01195 Boehringer Ingelheim Investigational Site
state: Florida
city: Panama City
country: United States
facility: 205.452.01197 Boehringer Ingelheim Investigational Site
state: Florida
city: Pembroke Pines
country: United States
facility: 205.452.01239 Boehringer Ingelheim Investigational Site
state: Florida
city: Pembroke Pines
country: United States
facility: 205.452.01247 Boehringer Ingelheim Investigational Site
state: Florida
city: Pembroke Pines
country: United States
facility: 205.452.01286 Boehringer Ingelheim Investigational Site
state: Florida
city: Pensacola
country: United States
facility: 205.452.01240 Boehringer Ingelheim Investigational Site
state: Florida
city: Ponte Vedra
country: United States
facility: 205.452.01260 Boehringer Ingelheim Investigational Site
state: Florida
city: Rockledge
country: United States
facility: 205.452.01092 Boehringer Ingelheim Investigational Site
state: Florida
city: Sarasota
country: United States
facility: 205.452.01251 Boehringer Ingelheim Investigational Site
state: Florida
city: St. Petersburg
country: United States
facility: 205.452.01133 Boehringer Ingelheim Investigational Site
state: Florida
city: St. Petersburg
country: United States
facility: 205.452.01136 Boehringer Ingelheim Investigational Site
state: Florida
city: St. Petersburg
country: United States
facility: 205.452.01207 Boehringer Ingelheim Investigational Site
state: Florida
city: Tamarac
country: United States
facility: 205.452.01134 Boehringer Ingelheim Investigational Site
state: Florida
city: Tamarac
country: United States
facility: 205.452.01231 Boehringer Ingelheim Investigational Site
state: Florida
city: Tampa
country: United States
facility: 205.452.01025 Boehringer Ingelheim Investigational Site
state: Florida
city: Tampa
country: United States
facility: 205.452.01250 Boehringer Ingelheim Investigational Site
state: Florida
city: Winter Park
country: United States
facility: 205.452.01060 Boehringer Ingelheim Investigational Site
state: Florida
city: Atlanta
country: United States
facility: 205.452.01130 Boehringer Ingelheim Investigational Site
state: Georgia
city: Austell
country: United States
facility: 205.452.01047 Boehringer Ingelheim Investigational Site
state: Georgia
city: Columbus
country: United States
facility: 205.452.01255 Boehringer Ingelheim Investigational Site
state: Georgia
city: Conyers
country: United States
facility: 205.452.01012 Boehringer Ingelheim Investigational Site
state: Georgia
city: Gainesville
country: United States
facility: 205.452.01299 Boehringer Ingelheim Investigational Site
state: Georgia
city: Lawrenceville
country: United States
facility: 205.452.01288 Boehringer Ingelheim Investigational Site
state: Georgia
city: Snellville
country: United States
facility: 205.452.01090 Boehringer Ingelheim Investigational Site
state: Georgia
city: Honolulu
country: United States
facility: 205.452.01100 Boehringer Ingelheim Investigational Site
state: Hawaii
city: Boise
country: United States
facility: 205.452.01165 Boehringer Ingelheim Investigational Site
state: Idaho
city: Coeur d'Alene
country: United States
facility: 205.452.01059 Boehringer Ingelheim Investigational Site
state: Idaho
city: Eagle
country: United States
facility: 205.452.01062 Boehringer Ingelheim Investigational Site
state: Idaho
city: Hayden Lake
country: United States
facility: 205.452.01166 Boehringer Ingelheim Investigational Site
state: Idaho
city: Meridian
country: United States
facility: 205.452.01275 Boehringer Ingelheim Investigational Site
state: Idaho
city: Arlington Heights
country: United States
facility: 205.452.01330 Boehringer Ingelheim Investigational Site
state: Illinois
city: Belleville
country: United States
facility: 205.452.01248 Boehringer Ingelheim Investigational Site
state: Illinois
city: Chicago
country: United States
facility: 205.452.01278 Boehringer Ingelheim Investigational Site
state: Illinois
city: Downer Grove
country: United States
facility: 205.452.01371 Boehringer Ingelheim Investigational Site
state: Illinois
city: Lombard
country: United States
facility: 205.452.01235 Boehringer Ingelheim Investigational Site
state: Illinois
city: O'Fallon
country: United States
facility: 205.452.01180 Boehringer Ingelheim Investigational Site
state: Illinois
city: Oak Park
country: United States
facility: 205.452.01268 Boehringer Ingelheim Investigational Site
state: Illinois
city: Quincy
country: United States
facility: 205.452.01359 Boehringer Ingelheim Investigational Site
state: Illinois
city: Brownsburg
country: United States
facility: 205.452.01347 Boehringer Ingelheim Investigational Site
state: Indiana
city: Evansville
country: United States
facility: 205.452.01153 Boehringer Ingelheim Investigational Site
state: Indiana
city: Fishers
country: United States
facility: 205.452.01301 Boehringer Ingelheim Investigational Site
state: Indiana
city: Franklin
country: United States
facility: 205.452.01141 Boehringer Ingelheim Investigational Site
state: Indiana
city: Lafayette
country: United States
facility: 205.452.01137 Boehringer Ingelheim Investigational Site
state: Indiana
city: Muncie
country: United States
facility: 205.452.01263 Boehringer Ingelheim Investigational Site
state: Indiana
city: Council Bluffs
country: United States
facility: 205.452.01284 Boehringer Ingelheim Investigational Site
state: Iowa
city: Dubuque
country: United States
facility: 205.452.01021 Boehringer Ingelheim Investigational Site
state: Iowa
city: Lansing
country: United States
facility: 205.452.01305 Boehringer Ingelheim Investigational Site
state: Kansas
city: Olathe
country: United States
facility: 205.452.01304 Boehringer Ingelheim Investigational Site
state: Kansas
city: Overland Park
country: United States
facility: 205.452.01125 Boehringer Ingelheim Investigational Site
state: Kansas
city: Topeka
country: United States
facility: 205.452.01068 Boehringer Ingelheim Investigational Site
state: Kansas
city: Bowling Green
country: United States
facility: 205.452.01063 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Fort Mitchell
country: United States
facility: 205.452.01206 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Louisville
country: United States
facility: 205.452.01289 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Paducah
country: United States
facility: 205.452.01152 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Lafayette
country: United States
facility: 205.452.01015 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Shreveport
country: United States
facility: 205.452.01091 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Shreveport
country: United States
facility: 205.452.01329 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Auburn
country: United States
facility: 205.452.01364 Boehringer Ingelheim Investigational Site
state: Maine
city: Bangor
country: United States
facility: 205.452.01169 Boehringer Ingelheim Investigational Site
state: Maine
city: Biddeford
country: United States
facility: 205.452.01022 Boehringer Ingelheim Investigational Site
state: Maine
city: Baltimore
country: United States
facility: 205.452.01053 Boehringer Ingelheim Investigational Site
state: Maryland
city: Elkridge
country: United States
facility: 205.452.01190 Boehringer Ingelheim Investigational Site
state: Maryland
city: Hollywood
country: United States
facility: 205.452.01336 Boehringer Ingelheim Investigational Site
state: Maryland
city: Towson
country: United States
facility: 205.452.01238 Boehringer Ingelheim Investigational Site
state: Maryland
city: Towson
country: United States
facility: 205.452.01243 Boehringer Ingelheim Investigational Site
state: Maryland
city: Fall River
country: United States
facility: 205.452.01366 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Haverhill
country: United States
facility: 205.452.01269 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: New Bedford
country: United States
facility: 205.452.01208 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Worcester
country: United States
facility: 205.452.01170 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Ann Arbor
country: United States
facility: 205.452.01270 Boehringer Ingelheim Investigational Site
state: Michigan
city: Benzonia
country: United States
facility: 205.452.01349 Boehringer Ingelheim Investigational Site
state: Michigan
city: Chelsea
country: United States
facility: 205.452.01365 Boehringer Ingelheim Investigational Site
state: Michigan
city: Chesterfield
country: United States
facility: 205.452.01149 Boehringer Ingelheim Investigational Site
state: Michigan
city: Detroit
country: United States
facility: 205.452.01146 Boehringer Ingelheim Investigational Site
state: Michigan
city: Interlochen
country: United States
facility: 205.452.01139 Boehringer Ingelheim Investigational Site
state: Michigan
city: Kalamazoo
country: United States
facility: 205.452.01080 Boehringer Ingelheim Investigational Site
state: Michigan
city: Stevensville
country: United States
facility: 205.452.01310 Boehringer Ingelheim Investigational Site
state: Michigan
city: Traverse City
country: United States
facility: 205.452.01122 Boehringer Ingelheim Investigational Site
state: Michigan
city: Troy
country: United States
facility: 205.452.01081 Boehringer Ingelheim Investigational Site
state: Michigan
city: Troy
country: United States
facility: 205.452.01221 Boehringer Ingelheim Investigational Site
state: Michigan
city: Chaska
country: United States
facility: 205.452.01205 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Edina
country: United States
facility: 205.452.01211 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Fridley
country: United States
facility: 205.452.01104 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Minneapolis
country: United States
facility: 205.452.01113 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Rochester
country: United States
facility: 205.452.01042 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Olive Branch
country: United States
facility: 205.452.01019 Boehringer Ingelheim Investigational Site
state: Mississippi
city: Chesterfield
country: United States
facility: 205.452.01014 Boehringer Ingelheim Investigational Site
state: Missouri
city: St. Charles
country: United States
facility: 205.452.01129 Boehringer Ingelheim Investigational Site
state: Missouri
city: St. Louis
country: United States
facility: 205.452.01110 Boehringer Ingelheim Investigational Site
state: Missouri
city: West Plains
country: United States
facility: 205.452.01179 Boehringer Ingelheim Investigational Site
state: Missouri
city: Billings
country: United States
facility: 205.452.01226 Boehringer Ingelheim Investigational Site
state: Montana
city: Butte
country: United States
facility: 205.452.01076 Boehringer Ingelheim Investigational Site
state: Montana
city: Missoula
country: United States
facility: 205.452.01196 Boehringer Ingelheim Investigational Site
state: Montana
city: Bellevue
country: United States
facility: 205.452.01150 Boehringer Ingelheim Investigational Site
state: Nebraska
city: Fremont
country: United States
facility: 205.452.01187 Boehringer Ingelheim Investigational Site
state: Nebraska
city: Omaha
country: United States
facility: 205.452.01155 Boehringer Ingelheim Investigational Site
state: Nebraska
city: Henderson
country: United States
facility: 205.452.01073 Boehringer Ingelheim Investigational Site
state: Nevada
city: Las Vegas
country: United States
facility: 205.452.01031 Boehringer Ingelheim Investigational Site
state: Nevada
city: Las Vegas
country: United States
facility: 205.452.01261 Boehringer Ingelheim Investigational Site
state: Nevada
city: Lebanon
country: United States
facility: 205.452.01026 Boehringer Ingelheim Investigational Site
state: New Hampshire
city: Newington
country: United States
facility: 205.452.01369 Boehringer Ingelheim Investigational Site
state: New Hampshire
city: Ocean
country: United States
facility: 205.452.01296 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Toms River
country: United States
facility: 205.452.01046 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Albuquerque
country: United States
facility: 205.452.01061 Boehringer Ingelheim Investigational Site
state: New Mexico
city: Albuquerque
country: United States
facility: 205.452.01167 Boehringer Ingelheim Investigational Site
state: New Mexico
city: Bayside
country: United States
facility: 205.452.01159 Boehringer Ingelheim Investigational Site
state: New York
city: Bronxville
country: United States
facility: 205.452.01163 Boehringer Ingelheim Investigational Site
state: New York
city: Cooperstown
country: United States
facility: 205.452.01194 Boehringer Ingelheim Investigational Site
state: New York
city: Elmira
country: United States
facility: 205.452.01131 Boehringer Ingelheim Investigational Site
state: New York
city: Endwell
country: United States
facility: 205.452.01142 Boehringer Ingelheim Investigational Site
state: New York
city: Glens Falls
country: United States
facility: 205.452.01192 Boehringer Ingelheim Investigational Site
state: New York
city: Great Neck
country: United States
facility: 205.452.01279 Boehringer Ingelheim Investigational Site
state: New York
city: Honeoye Falls
country: United States
facility: 205.452.01328 Boehringer Ingelheim Investigational Site
state: New York
city: New Windsor
country: United States
facility: 205.452.01118 Boehringer Ingelheim Investigational Site
state: New York
city: New York
country: United States
facility: 205.452.01127 Boehringer Ingelheim Investigational Site
state: New York
city: Rochester
country: United States
facility: 205.452.01058 Boehringer Ingelheim Investigational Site
state: New York
city: Syracuse
country: United States
facility: 205.452.01085 Boehringer Ingelheim Investigational Site
state: New York
city: Syracuse
country: United States
facility: 205.452.01293 Boehringer Ingelheim Investigational Site
state: New York
city: Vestal
country: United States
facility: 205.452.01151 Boehringer Ingelheim Investigational Site
state: New York
city: Westfield
country: United States
facility: 205.452.01188 Boehringer Ingelheim Investigational Site
state: New York
city: Asheville
country: United States
facility: 205.452.01271 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Burlington
country: United States
facility: 205.452.01101 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Calabash
country: United States
facility: 205.452.01264 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Charlotte
country: United States
facility: 205.452.01168 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Elizabeth City
country: United States
facility: 205.452.01108 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Greensboro
country: United States
facility: 205.452.01033 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Greensboro
country: United States
facility: 205.452.01172 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Hickory
country: United States
facility: 205.452.01098 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Hickory
country: United States
facility: 205.452.01115 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Raleigh
country: United States
facility: 205.452.01128 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Rocky Mount
country: United States
facility: 205.452.01352 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Salisbury
country: United States
facility: 205.452.01348 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Statesville
country: United States
facility: 205.452.01032 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Tabor City
country: United States
facility: 205.452.01276 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Wilmington
country: United States
facility: 205.452.01157 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Winston Salem
country: United States
facility: 205.452.01363 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Canal Fulton
country: United States
facility: 205.452.01193 Boehringer Ingelheim Investigational Site
state: Ohio
city: Centerville
country: United States
facility: 205.452.01374 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cincinnati
country: United States
facility: 205.452.01006 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cincinnati
country: United States
facility: 205.452.01373 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cleveland
country: United States
facility: 205.452.01314 Boehringer Ingelheim Investigational Site
state: Ohio
city: Columbus
country: United States
facility: 205.452.01210 Boehringer Ingelheim Investigational Site
state: Ohio
city: Columbus
country: United States
facility: 205.452.01232 Boehringer Ingelheim Investigational Site
state: Ohio
city: Dayton
country: United States
facility: 205.452.01309 Boehringer Ingelheim Investigational Site
state: Ohio
city: Delaware
country: United States
facility: 205.452.01140 Boehringer Ingelheim Investigational Site
state: Ohio
city: Sylvania
country: United States
facility: 205.452.01084 Boehringer Ingelheim Investigational Site
state: Ohio
city: Toledo
country: United States
facility: 205.452.01287 Boehringer Ingelheim Investigational Site
state: Ohio
city: Oklahoma City
country: United States
facility: 205.452.01010 Boehringer Ingelheim Investigational Site
state: Oklahoma
city: Oklahoma City
country: United States
facility: 205.452.01094 Boehringer Ingelheim Investigational Site
state: Oklahoma
city: Tulsa
country: United States
facility: 205.452.01029 Boehringer Ingelheim Investigational Site
state: Oklahoma
city: Tulsa
country: United States
facility: 205.452.01043 Boehringer Ingelheim Investigational Site
state: Oklahoma
city: Ashland
country: United States
facility: 205.452.01266 Boehringer Ingelheim Investigational Site
state: Oregon
city: Bend
country: United States
facility: 205.452.01083 Boehringer Ingelheim Investigational Site
state: Oregon
city: Corvallis
country: United States
facility: 205.452.01189 Boehringer Ingelheim Investigational Site
state: Oregon
city: Springfield
country: United States
facility: 205.452.01341 Boehringer Ingelheim Investigational Site
state: Oregon
city: Altoona
country: United States
facility: 205.452.01002 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Beaver
country: United States
facility: 205.452.01354 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Carnegie
country: United States
facility: 205.452.01143 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Downingtown
country: United States
facility: 205.452.01320 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Erie
country: United States
facility: 205.452.01323 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Jefferson Hills
country: United States
facility: 205.452.01257 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Langhorne
country: United States
facility: 205.452.01332 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Norristown
country: United States
facility: 205.452.01075 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Philadelphia
country: United States
facility: 205.452.01087 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Philadelphia
country: United States
facility: 205.452.01144 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pittsburgh
country: United States
facility: 205.452.01003 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pittsburgh
country: United States
facility: 205.452.01361 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pleasant Hills
country: United States
facility: 205.452.01036 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Uniontown
country: United States
facility: 205.452.01106 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Uniontown
country: United States
facility: 205.452.01156 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Warminster
country: United States
facility: 205.452.01204 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Wyomissing
country: United States
facility: 205.452.01338 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Cranston
country: United States
facility: 205.452.01267 Boehringer Ingelheim Investigational Site
state: Rhode Island
city: Johnston
country: United States
facility: 205.452.01214 Boehringer Ingelheim Investigational Site
state: Rhode Island
city: Anderson
country: United States
facility: 205.452.01340 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Charleston
country: United States
facility: 205.452.01066 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Columbia
country: United States
facility: 205.452.01217 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Easley
country: United States
facility: 205.452.01303 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Florence
country: United States
facility: 205.452.01259 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Gaffney
country: United States
facility: 205.452.01013 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Greenville
country: United States
facility: 205.452.01077 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Greer
country: United States
facility: 205.452.01093 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Hodges
country: United States
facility: 205.452.01295 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Myrtle Beach
country: United States
facility: 205.452.01335 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Rock Hill
country: United States
facility: 205.452.01056 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Spartanburg
country: United States
facility: 205.452.01294 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Rapid City
country: United States
facility: 205.452.01004 Boehringer Ingelheim Investigational Site
state: South Dakota
city: Brentwood
country: United States
facility: 205.452.01126 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Chattanooga
country: United States
facility: 205.452.01220 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Chattanooga
country: United States
facility: 205.452.01324 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Kingsport
country: United States
facility: 205.452.01342 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Arlington
country: United States
facility: 205.452.01096 Boehringer Ingelheim Investigational Site
state: Texas
city: Corsicana
country: United States
facility: 205.452.01050 Boehringer Ingelheim Investigational Site
state: Texas
city: Dallas
country: United States
facility: 205.452.01233 Boehringer Ingelheim Investigational Site
state: Texas
city: Dallas
country: United States
facility: 205.452.01334 Boehringer Ingelheim Investigational Site
state: Texas
city: Fort Worth
country: United States
facility: 205.452.01057 Boehringer Ingelheim Investigational Site
state: Texas
city: Fort Worth
country: United States
facility: 205.452.01181 Boehringer Ingelheim Investigational Site
state: Texas
city: Fort Worth
country: United States
facility: 205.452.01272 Boehringer Ingelheim Investigational Site
state: Texas
city: Houston
country: United States
facility: 205.452.01082 Boehringer Ingelheim Investigational Site
state: Texas
city: Houston
country: United States
facility: 205.452.01105 Boehringer Ingelheim Investigational Site
state: Texas
city: Houston
country: United States
facility: 205.452.01178 Boehringer Ingelheim Investigational Site
state: Texas
city: Houston
country: United States
facility: 205.452.01212 Boehringer Ingelheim Investigational Site
state: Texas
city: Longview
country: United States
facility: 205.452.01274 Boehringer Ingelheim Investigational Site
state: Texas
city: McKinney
country: United States
facility: 205.452.01116 Boehringer Ingelheim Investigational Site
state: Texas
city: Richardson
country: United States
facility: 205.452.01262 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 205.452.01055 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 205.452.01182 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 205.452.01186 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 205.452.01353 Boehringer Ingelheim Investigational Site
state: Texas
city: Sugar Land
country: United States
facility: 205.452.01215 Boehringer Ingelheim Investigational Site
state: Texas
city: Midvale
country: United States
facility: 205.452.01223 Boehringer Ingelheim Investigational Site
state: Utah
city: Salt Lake City
country: United States
facility: 205.452.01001 Boehringer Ingelheim Investigational Site
state: Utah
city: Abingdon
country: United States
facility: 205.452.01079 Boehringer Ingelheim Investigational Site
state: Virginia
city: Alexandria
country: United States
facility: 205.452.01234 Boehringer Ingelheim Investigational Site
state: Virginia
city: Danville
country: United States
facility: 205.452.01065 Boehringer Ingelheim Investigational Site
state: Virginia
city: Danville
country: United States
facility: 205.452.01285 Boehringer Ingelheim Investigational Site
state: Virginia
city: Ettrick
country: United States
facility: 205.452.01045 Boehringer Ingelheim Investigational Site
state: Virginia
city: Lynchburg
country: United States
facility: 205.452.01030 Boehringer Ingelheim Investigational Site
state: Virginia
city: Richmond
country: United States
facility: 205.452.01016 Boehringer Ingelheim Investigational Site
state: Virginia
city: Richmond
country: United States
facility: 205.452.01039 Boehringer Ingelheim Investigational Site
state: Virginia
city: Richmond
country: United States
facility: 205.452.01044 Boehringer Ingelheim Investigational Site
state: Virginia
city: Richmond
country: United States
facility: 205.452.01300 Boehringer Ingelheim Investigational Site
state: Virginia
city: Selah
country: United States
facility: 205.452.01099 Boehringer Ingelheim Investigational Site
state: Washington
city: Spokane
country: United States
facility: 205.452.01008 Boehringer Ingelheim Investigational Site
state: Washington
city: Spokane
country: United States
facility: 205.452.01069 Boehringer Ingelheim Investigational Site
state: Washington
city: Spokane
country: United States
facility: 205.452.01145 Boehringer Ingelheim Investigational Site
state: Washington
city: Tacoma
country: United States
facility: 205.452.01185 Boehringer Ingelheim Investigational Site
state: Washington
city: Wenatchee
country: United States
facility: 205.452.01007 Boehringer Ingelheim Investigational Site
state: Washington
city: Oregon
country: United States
facility: 205.452.01201 Boehringer Ingelheim Investigational Site
state: Wisconsin
city: West Allis
country: United States
facility: 205.452.01344 Boehringer Ingelheim Investigational Site
state: Wisconsin
city: Capital Federal
country: Argentina
facility: 205.452.54003 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 205.452.54011 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 205.452.54013 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 205.452.54027 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 205.452.54029 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 205.452.54031 Boehringer Ingelheim Investigational Site
city: Florencio Varela
country: Argentina
facility: 205.452.54025 Boehringer Ingelheim Investigational Site
city: Mar del Plata
country: Argentina
facility: 205.452.54007 Boehringer Ingelheim Investigational Site
city: Mar del Plata
country: Argentina
facility: 205.452.54015 Boehringer Ingelheim Investigational Site
city: Mendoza
country: Argentina
facility: 205.452.54001 Boehringer Ingelheim Investigational Site
city: Monte Grande
country: Argentina
facility: 205.452.54019 Boehringer Ingelheim Investigational Site
city: Quilmes
country: Argentina
facility: 205.452.54005 Boehringer Ingelheim Investigational Site
city: Rosario
country: Argentina
facility: 205.452.54009 Boehringer Ingelheim Investigational Site
city: Rosario
country: Argentina
facility: 205.452.54021 Boehringer Ingelheim Investigational Site
city: San Miguel de Tucumán
country: Argentina
facility: 205.452.54017 Boehringer Ingelheim Investigational Site
city: San Miguel de Tucumán
country: Argentina
facility: 205.452.54023 Boehringer Ingelheim Investigational Site
city: Adelaide
country: Australia
facility: 205.452.61006 Boehringer Ingelheim Investigational Site
state: South Australia
city: Woodville
country: Australia
facility: 205.452.61002 Boehringer Ingelheim Investigational Site
state: South Australia
city: Box Hill
country: Australia
facility: 205.452.61004 Boehringer Ingelheim Investigational Site
state: Victoria
city: Footscray
country: Australia
facility: 205.452.61003 Boehringer Ingelheim Investigational Site
state: Victoria
city: Frankston
country: Australia
facility: 205.452.61001 Boehringer Ingelheim Investigational Site
state: Victoria
city: Nedlands
country: Australia
facility: 205.452.61005 Boehringer Ingelheim Investigational Site
state: Western Australia
city: Feldbach
country: Austria
facility: 205.452.43002 Boehringer Ingelheim Investigational Site
city: Hallein
country: Austria
facility: 205.452.43003 Boehringer Ingelheim Investigational Site
city: Thalheim bei Wels
country: Austria
facility: 205.452.43005 Boehringer Ingelheim Investigational Site
city: Godinne
country: Belgium
facility: 205.452.32009 Boehringer Ingelheim Investigational Site
city: Gozée
country: Belgium
facility: 205.452.32007 Boehringer Ingelheim Investigational Site
city: Halen
country: Belgium
facility: 205.452.32002 Boehringer Ingelheim Investigational Site
city: Leuven
country: Belgium
facility: 205.452.32001 Boehringer Ingelheim Investigational Site
city: Linkebeek
country: Belgium
facility: 205.452.32006 Boehringer Ingelheim Investigational Site
city: Merksem
country: Belgium
facility: 205.452.32005 Boehringer Ingelheim Investigational Site
city: Natoye
country: Belgium
facility: 205.452.32008 Boehringer Ingelheim Investigational Site
city: Tessenderlo
country: Belgium
facility: 205.452.32003 Boehringer Ingelheim Investigational Site
city: Zichem
country: Belgium
facility: 205.452.32004 Boehringer Ingelheim Investigational Site
city: Florianópolis
country: Brazil
facility: 205.452.55005 Boehringer Ingelheim Investigational Site
city: Passo Fundo - RS
country: Brazil
facility: 205.452.55010 Boehringer Ingelheim Investigational Site
city: Porto Alegre
country: Brazil
facility: 205.452.55001 Boehringer Ingelheim Investigational Site
city: Porto Alegre
country: Brazil
facility: 205.452.55002 Boehringer Ingelheim Investigational Site
city: Recife
country: Brazil
facility: 205.452.55003 Boehringer Ingelheim Investigational Site
city: Rio de Janeiro
country: Brazil
facility: 205.452.55004 Boehringer Ingelheim Investigational Site
city: Río de Janeiro
country: Brazil
facility: 205.452.55011 Boehringer Ingelheim Investigational Site
city: Sao Pablo
country: Brazil
facility: 205.452.55008 Boehringer Ingelheim Investigational Site
city: Sao Paulo
country: Brazil
facility: 205.452.55009 Boehringer Ingelheim Investigational Site
city: São Paulo
country: Brazil
facility: 205.452.55006 Boehringer Ingelheim Investigational Site
city: São Paulo
country: Brazil
facility: 205.452.55007 Boehringer Ingelheim Investigational Site
city: Plovdiv
country: Bulgaria
facility: 205.452.35909 Boehringer Ingelheim Investigational Site
city: Plovdiv
country: Bulgaria
facility: 205.452.35910 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35901 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35902 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35903 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35904 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35905 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35908 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35914 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 205.452.35915 Boehringer Ingelheim Investigational Site
city: Stara Zagora
country: Bulgaria
facility: 205.452.35912 Boehringer Ingelheim Investigational Site
city: Veliko Turnovo
country: Bulgaria
facility: 205.452.35906 Boehringer Ingelheim Investigational Site
city: Calgary
country: Canada
facility: 205.452.11015 Boehringer Ingelheim Investigational Site
state: Alberta
city: Calgary
country: Canada
facility: 205.452.11032 Boehringer Ingelheim Investigational Site
state: Alberta
city: Edmonton
country: Canada
facility: 205.452.11028 Boehringer Ingelheim Investigational Site
state: Alberta
city: Edmonton
country: Canada
facility: 205.452.11037 Boehringer Ingelheim Investigational Site
state: Alberta
city: Edmonton
country: Canada
facility: 205.452.11045 Boehringer Ingelheim Investigational Site
state: Alberta
city: Edmonton
country: Canada
facility: 205.452.11047 Boehringer Ingelheim Investigational Site
state: Alberta
city: Spruce Grove
country: Canada
facility: 205.452.11002 Boehringer Ingelheim Investigational Site
state: Alberta
city: Kelowna
country: Canada
facility: 205.452.11048 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Maple Ridge
country: Canada
facility: 205.452.11051 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Vancouver
country: Canada
facility: 205.452.11014 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Vancouver
country: Canada
facility: 205.452.11016 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Winnipeg
country: Canada
facility: 205.452.11025 Boehringer Ingelheim Investigational Site
state: Manitoba
city: Moncton
country: Canada
facility: 205.452.11033 Boehringer Ingelheim Investigational Site
state: New Brunswick
city: Saint John
country: Canada
facility: 205.452.11010 Boehringer Ingelheim Investigational Site
state: New Brunswick
city: Grand Falls-Windsor
country: Canada
facility: 205.452.11044 Boehringer Ingelheim Investigational Site
state: Newfoundland and Labrador
city: Mount Pearl
country: Canada
facility: 205.452.11053 Boehringer Ingelheim Investigational Site
state: Newfoundland and Labrador
city: St. John's
country: Canada
facility: 205.452.11017 Boehringer Ingelheim Investigational Site
state: Newfoundland and Labrador
city: St. John's
country: Canada
facility: 205.452.11021 Boehringer Ingelheim Investigational Site
state: Newfoundland and Labrador
city: Burlington
country: Canada
facility: 205.452.11030 Boehringer Ingelheim Investigational Site
state: Ontario
city: Corunna
country: Canada
facility: 205.452.11042 Boehringer Ingelheim Investigational Site
state: Ontario
city: Courtice
country: Canada
facility: 205.452.11049 Boehringer Ingelheim Investigational Site
state: Ontario
city: Downsview
country: Canada
facility: 205.452.11004 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 205.452.11009 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 205.452.11029 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 205.452.11050 Boehringer Ingelheim Investigational Site
state: Ontario
city: Kingston
country: Canada
facility: 205.452.11040 Boehringer Ingelheim Investigational Site
state: Ontario
city: London
country: Canada
facility: 205.452.11035 Boehringer Ingelheim Investigational Site
state: Ontario
city: Mississauga
country: Canada
facility: 205.452.11001 Boehringer Ingelheim Investigational Site
state: Ontario
city: Mississauga
country: Canada
facility: 205.452.11054 Boehringer Ingelheim Investigational Site
state: Ontario
city: Newmarket
country: Canada
facility: 205.452.11022 Boehringer Ingelheim Investigational Site
state: Ontario
city: Ottawa
country: Canada
facility: 205.452.11024 Boehringer Ingelheim Investigational Site
state: Ontario
city: Richmond Hill
country: Canada
facility: 205.452.11027 Boehringer Ingelheim Investigational Site
state: Ontario
city: Sarnia
country: Canada
facility: 205.452.11041 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 205.452.11019 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 205.452.11034 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 205.452.11052 Boehringer Ingelheim Investigational Site
state: Ontario
city: Windsor
country: Canada
facility: 205.452.11012 Boehringer Ingelheim Investigational Site
state: Ontario
city: Greenfield Park
country: Canada
facility: 205.452.11007 Boehringer Ingelheim Investigational Site
state: Quebec
city: La Malbaie
country: Canada
facility: 205.452.11005 Boehringer Ingelheim Investigational Site
state: Quebec
city: Longueuil
country: Canada
facility: 205.452.11006 Boehringer Ingelheim Investigational Site
state: Quebec
city: Montreal
country: Canada
facility: 205.452.11043 Boehringer Ingelheim Investigational Site
state: Quebec
city: Point Claire
country: Canada
facility: 205.452.11013 Boehringer Ingelheim Investigational Site
state: Quebec
city: Sherbrooke
country: Canada
facility: 205.452.11018 Boehringer Ingelheim Investigational Site
state: Quebec
city: St. Lambert
country: Canada
facility: 205.452.11020 Boehringer Ingelheim Investigational Site
state: Quebec
city: Trois-Rivieres
country: Canada
facility: 205.452.11026 Boehringer Ingelheim Investigational Site
state: Quebec
city: Saskatoon
country: Canada
facility: 205.452.11003 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Saskatoon
country: Canada
facility: 205.452.11011 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Saskatoon
country: Canada
facility: 205.452.11036 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Saskatoon
country: Canada
facility: 205.452.11039 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Quebec
country: Canada
facility: 205.452.11031 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 205.452.86009 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 205.452.86010 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 205.452.86011 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 205.452.86012 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 205.452.86038 Boehringer Ingelheim Investigational Site
city: Changchun
country: China
facility: 205.452.86026 Boehringer Ingelheim Investigational Site
city: Changsha
country: China
facility: 205.452.86024 Boehringer Ingelheim Investigational Site
city: Changsha
country: China
facility: 205.452.86025 Boehringer Ingelheim Investigational Site
city: Chengdu
country: China
facility: 205.452.86021 Boehringer Ingelheim Investigational Site
city: Chengdu
country: China
facility: 205.452.86032 Boehringer Ingelheim Investigational Site
city: Chongqing
country: China
facility: 205.452.86034 Boehringer Ingelheim Investigational Site
city: Chongqing
country: China
facility: 205.452.86035 Boehringer Ingelheim Investigational Site
city: Chongqing
country: China
facility: 205.452.86036 Boehringer Ingelheim Investigational Site
city: Foshan
country: China
facility: 205.452.86020 Boehringer Ingelheim Investigational Site
city: Guangzhou
country: China
facility: 205.452.86001 Boehringer Ingelheim Investigational Site
city: Guangzhou
country: China
facility: 205.452.86004 Boehringer Ingelheim Investigational Site
city: Guangzhou
country: China
facility: 205.452.86005 Boehringer Ingelheim Investigational Site
city: Guangzhou
country: China
facility: 205.452.86019 Boehringer Ingelheim Investigational Site
city: Guangzhou
country: China
facility: 205.452.86028 Boehringer Ingelheim Investigational Site
city: Haikou
country: China
facility: 205.452.86030 Boehringer Ingelheim Investigational Site
city: Hangzhou
country: China
facility: 205.452.86007 Boehringer Ingelheim Investigational Site
city: Hangzhou
country: China
facility: 205.452.86008 Boehringer Ingelheim Investigational Site
city: Nan Ning
country: China
facility: 205.452.86029 Boehringer Ingelheim Investigational Site
city: Nanchang
country: China
facility: 205.452.86037 Boehringer Ingelheim Investigational Site
city: Nanjing
country: China
facility: 205.452.86022 Boehringer Ingelheim Investigational Site
city: Qingdao
country: China
facility: 205.452.86027 Boehringer Ingelheim Investigational Site
city: Shanghai
country: China
facility: 205.452.86002 Boehringer Ingelheim Investigational Site
city: Shanghai
country: China
facility: 205.452.86003 Boehringer Ingelheim Investigational Site
city: Shanghai
country: China
facility: 205.452.86018 Boehringer Ingelheim Investigational Site
city: Shenyang
country: China
facility: 205.452.86014 Boehringer Ingelheim Investigational Site
city: Shenyang
country: China
facility: 205.452.86015 Boehringer Ingelheim Investigational Site
city: Suzhou
country: China
facility: 205.452.86006 Boehringer Ingelheim Investigational Site
city: Tianjin
country: China
facility: 205.452.86033 Boehringer Ingelheim Investigational Site
city: Wuhan
country: China
facility: 205.452.86031 Boehringer Ingelheim Investigational Site
city: Xi'An
country: China
facility: 205.452.86016 Boehringer Ingelheim Investigational Site
city: Xi'An
country: China
facility: 205.452.86017 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 205.452.57002 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 205.452.57004 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 205.452.57005 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 205.452.57006 Boehringer Ingelheim Investigational Site
city: Medellín
country: Colombia
facility: 205.452.57001 Boehringer Ingelheim Investigational Site
city: Cakovec
country: Croatia
facility: 205.452.38512 Boehringer Ingelheim Investigational Site
city: Dubrovnik
country: Croatia
facility: 205.452.38508 Boehringer Ingelheim Investigational Site
city: Osijek
country: Croatia
facility: 205.452.38510 Boehringer Ingelheim Investigational Site
city: Rijeka
country: Croatia
facility: 205.452.38501 Boehringer Ingelheim Investigational Site
city: Sisak
country: Croatia
facility: 205.452.38506 Boehringer Ingelheim Investigational Site
city: Split
country: Croatia
facility: 205.452.38502 Boehringer Ingelheim Investigational Site
city: Split
country: Croatia
facility: 205.452.38503 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 205.452.38504 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 205.452.38505 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 205.452.38507 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 205.452.38509 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 205.452.38511 Boehringer Ingelheim Investigational Site
city: Aalborg
country: Denmark
facility: 205.452.45002 Boehringer Ingelheim Investigational Site
city: Aarhus C
country: Denmark
facility: 205.452.45003 Boehringer Ingelheim Investigational Site
city: Birkerød
country: Denmark
facility: 205.452.45006 Boehringer Ingelheim Investigational Site
city: Kolding
country: Denmark
facility: 205.452.45013 Boehringer Ingelheim Investigational Site
city: København NV
country: Denmark
facility: 205.452.45001 Boehringer Ingelheim Investigational Site
city: København S
country: Denmark
facility: 205.452.45005 Boehringer Ingelheim Investigational Site
city: Odense C
country: Denmark
facility: 205.452.45012 Boehringer Ingelheim Investigational Site
city: Roskilde
country: Denmark
facility: 205.452.45016 Boehringer Ingelheim Investigational Site
city: Rødovre
country: Denmark
facility: 205.452.45009 Boehringer Ingelheim Investigational Site
city: Rødovre
country: Denmark
facility: 205.452.45010 Boehringer Ingelheim Investigational Site
city: Silkeborg
country: Denmark
facility: 205.452.45004 Boehringer Ingelheim Investigational Site
city: Skive
country: Denmark
facility: 205.452.45014 Boehringer Ingelheim Investigational Site
city: Sønderborg
country: Denmark
facility: 205.452.45011 Boehringer Ingelheim Investigational Site
city: Viby
country: Denmark
facility: 205.452.45015 Boehringer Ingelheim Investigational Site
city: Værløse
country: Denmark
facility: 205.452.45007 Boehringer Ingelheim Investigational Site
city: Helsinki
country: Finland
facility: 205.452.35801 Boehringer Ingelheim Investigational Site
city: Lahti
country: Finland
facility: 205.452.35804 Boehringer Ingelheim Investigational Site
city: Pori
country: Finland
facility: 205.452.35808 Boehringer Ingelheim Investigational Site
city: Porvoo
country: Finland
facility: 205.452.35805 Boehringer Ingelheim Investigational Site
city: Tammisaari
country: Finland
facility: 205.452.35806 Boehringer Ingelheim Investigational Site
city: Tampere
country: Finland
facility: 205.452.35802 Boehringer Ingelheim Investigational Site
city: Turku
country: Finland
facility: 205.452.35803 Boehringer Ingelheim Investigational Site
city: Albens
country: France
facility: 205.452.33087 Boehringer Ingelheim Investigational Site
city: Angers
country: France
facility: 205.452.33028 Boehringer Ingelheim Investigational Site
city: Angers
country: France
facility: 205.452.33055 Boehringer Ingelheim Investigational Site
city: Angers
country: France
facility: 205.452.33142 Boehringer Ingelheim Investigational Site
city: Angers
country: France
facility: 205.452.33159 Boehringer Ingelheim Investigational Site
city: Anzin
country: France
facility: 205.452.33030 Boehringer Ingelheim Investigational Site
city: Arras
country: France
facility: 205.452.33158 Boehringer Ingelheim Investigational Site
city: Avrillé
country: France
facility: 205.452.33084 Boehringer Ingelheim Investigational Site
city: Becon les Granits
country: France
facility: 205.452.33128 Boehringer Ingelheim Investigational Site
city: Bersée
country: France
facility: 205.452.33029 Boehringer Ingelheim Investigational Site
city: Beziers
country: France
facility: 205.452.33018 Boehringer Ingelheim Investigational Site
city: Bischheim
country: France
facility: 205.452.33053 Boehringer Ingelheim Investigational Site
city: Blois
country: France
facility: 205.452.33024 Boehringer Ingelheim Investigational Site
city: Bort les Orgues
country: France
facility: 205.452.33043 Boehringer Ingelheim Investigational Site
city: Bourg des cptes
country: France
facility: 205.452.33091 Boehringer Ingelheim Investigational Site
city: Briollay
country: France
facility: 205.452.33123 Boehringer Ingelheim Investigational Site
city: Broglie
country: France
facility: 205.452.33063 Boehringer Ingelheim Investigational Site
city: Bruay La Buissiere
country: France
facility: 205.452.33074 Boehringer Ingelheim Investigational Site
city: Cannes Cedex
country: France
facility: 205.452.33010 Boehringer Ingelheim Investigational Site
city: Cannes
country: France
facility: 205.452.33118 Boehringer Ingelheim Investigational Site
city: Chamalières
country: France
facility: 205.452.33009 Boehringer Ingelheim Investigational Site
city: Chambery
country: France
facility: 205.452.33073 Boehringer Ingelheim Investigational Site
city: Chateau Renault
country: France
facility: 205.452.33059 Boehringer Ingelheim Investigational Site
city: Colombey les Belles
country: France
facility: 205.452.33089 Boehringer Ingelheim Investigational Site
city: Cournonterral
country: France
facility: 205.452.33099 Boehringer Ingelheim Investigational Site
city: Cournonterral
country: France
facility: 205.452.33127 Boehringer Ingelheim Investigational Site
city: Croix
country: France
facility: 205.452.33162 Boehringer Ingelheim Investigational Site
city: Dinard
country: France
facility: 205.452.33105 Boehringer Ingelheim Investigational Site
city: Donges
country: France
facility: 205.452.33110 Boehringer Ingelheim Investigational Site
city: Gambsheim
country: France
facility: 205.452.33094 Boehringer Ingelheim Investigational Site
city: Grenoble
country: France
facility: 205.452.33046 Boehringer Ingelheim Investigational Site
city: Hautmont
country: France
facility: 205.452.33096 Boehringer Ingelheim Investigational Site
city: Hinx
country: France
facility: 205.452.33090 Boehringer Ingelheim Investigational Site
city: Jarny
country: France
facility: 205.452.33145 Boehringer Ingelheim Investigational Site
city: La Bouëxière
country: France
facility: 205.452.33154 Boehringer Ingelheim Investigational Site
city: La Chapelle sur Erdre
country: France
facility: 205.452.33065 Boehringer Ingelheim Investigational Site
city: La Montagne
country: France
facility: 205.452.33102 Boehringer Ingelheim Investigational Site
city: La Riche
country: France
facility: 205.452.33100 Boehringer Ingelheim Investigational Site
city: Lambersart
country: France
facility: 205.452.33058 Boehringer Ingelheim Investigational Site
city: Lambersart
country: France
facility: 205.452.33098 Boehringer Ingelheim Investigational Site
city: Levallois Perret
country: France
facility: 205.452.33103 Boehringer Ingelheim Investigational Site
city: Louvigne De bais
country: France
facility: 205.452.33164 Boehringer Ingelheim Investigational Site
city: Luynes
country: France
facility: 205.452.33111 Boehringer Ingelheim Investigational Site
city: Marcq en Baroeul
country: France
facility: 205.452.33136 Boehringer Ingelheim Investigational Site
city: Mondelange
country: France
facility: 205.452.33115 Boehringer Ingelheim Investigational Site
city: Mont de Marsan
country: France
facility: 205.452.33088 Boehringer Ingelheim Investigational Site
city: Mont de Marsan
country: France
facility: 205.452.33138 Boehringer Ingelheim Investigational Site
city: Montigny les Metz
country: France
facility: 205.452.33005 Boehringer Ingelheim Investigational Site
city: Mundolsheim
country: France
facility: 205.452.33163 Boehringer Ingelheim Investigational Site
city: Murs Erigne
country: France
facility: 205.452.33109 Boehringer Ingelheim Investigational Site
city: Nantes
country: France
facility: 205.452.33031 Boehringer Ingelheim Investigational Site
city: Nice
country: France
facility: 205.452.33003 Boehringer Ingelheim Investigational Site
city: Oignies
country: France
facility: 205.452.33108 Boehringer Ingelheim Investigational Site
city: Ollioules
country: France
facility: 205.452.33014 Boehringer Ingelheim Investigational Site
city: Orthez
country: France
facility: 205.452.33157 Boehringer Ingelheim Investigational Site
city: Parcay les Pins
country: France
facility: 205.452.33112 Boehringer Ingelheim Investigational Site
city: Paris
country: France
facility: 205.452.33001 Boehringer Ingelheim Investigational Site
city: Paris
country: France
facility: 205.452.33051 Boehringer Ingelheim Investigational Site
city: Paris
country: France
facility: 205.452.33082 Boehringer Ingelheim Investigational Site
city: Paris
country: France
facility: 205.452.33165 Boehringer Ingelheim Investigational Site
city: Pont à Mousson
country: France
facility: 205.452.33130 Boehringer Ingelheim Investigational Site
city: Quarouble
country: France
facility: 205.452.33122 Boehringer Ingelheim Investigational Site
city: Reims
country: France
facility: 205.452.33006 Boehringer Ingelheim Investigational Site
city: Rosiers d'Egletons
country: France
facility: 205.452.33153 Boehringer Ingelheim Investigational Site
city: Rugles
country: France
facility: 205.452.33161 Boehringer Ingelheim Investigational Site
city: Saint Alban Leysse
country: France
facility: 205.452.33126 Boehringer Ingelheim Investigational Site
city: Saint Aulaire
country: France
facility: 205.452.33140 Boehringer Ingelheim Investigational Site
city: Saint Avertin
country: France
facility: 205.452.33052 Boehringer Ingelheim Investigational Site
city: Saint Léger des Bois
country: France
facility: 205.452.33011 Boehringer Ingelheim Investigational Site
city: Saintes
country: France
facility: 205.452.33002 Boehringer Ingelheim Investigational Site
city: Salies de Bearn
country: France
facility: 205.452.33148 Boehringer Ingelheim Investigational Site
city: Savonnières
country: France
facility: 205.452.33026 Boehringer Ingelheim Investigational Site
city: Segre
country: France
facility: 205.452.33067 Boehringer Ingelheim Investigational Site
city: Serres Casset
country: France
facility: 205.452.33040 Boehringer Ingelheim Investigational Site
city: Six Four les Plages
country: France
facility: 205.452.33012 Boehringer Ingelheim Investigational Site
city: St Jouan des Guerets
country: France
facility: 205.452.33160 Boehringer Ingelheim Investigational Site
city: St Sebastien sur Loire
country: France
facility: 205.452.33079 Boehringer Ingelheim Investigational Site
city: Strasbourg
country: France
facility: 205.452.33007 Boehringer Ingelheim Investigational Site
city: Strasbourg
country: France
facility: 205.452.33033 Boehringer Ingelheim Investigational Site
city: Strasbourg
country: France
facility: 205.452.33097 Boehringer Ingelheim Investigational Site
city: Strasbourg
country: France
facility: 205.452.33101 Boehringer Ingelheim Investigational Site
city: Thouars
country: France
facility: 205.452.33107 Boehringer Ingelheim Investigational Site
city: Tinténiac
country: France
facility: 205.452.33116 Boehringer Ingelheim Investigational Site
city: Toulon
country: France
facility: 205.452.33013 Boehringer Ingelheim Investigational Site
city: Tours
country: France
facility: 205.452.33054 Boehringer Ingelheim Investigational Site
city: Tours
country: France
facility: 205.452.33064 Boehringer Ingelheim Investigational Site
city: Tours
country: France
facility: 205.452.33092 Boehringer Ingelheim Investigational Site
city: Tours
country: France
facility: 205.452.33124 Boehringer Ingelheim Investigational Site
city: Vendôme
country: France
facility: 205.452.33066 Boehringer Ingelheim Investigational Site
city: Vernoil
country: France
facility: 205.452.33137 Boehringer Ingelheim Investigational Site
city: Vieux Condé
country: France
facility: 205.452.33032 Boehringer Ingelheim Investigational Site
city: Vihiers
country: France
facility: 205.452.33151 Boehringer Ingelheim Investigational Site
city: Villey St Etienne
country: France
facility: 205.452.33077 Boehringer Ingelheim Investigational Site
city: Wattrelos
country: France
facility: 205.452.33135 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99501 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99502 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99503 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99504 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99505 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99506 Boehringer Ingelheim Investigational Site
city: Tbilisi
country: Georgia
facility: 205.452.99507 Boehringer Ingelheim Investigational Site
city: Aschaffenburg
country: Germany
facility: 205.452.49096 Boehringer Ingelheim Investigational Site
city: Augsburg
country: Germany
facility: 205.452.49130 Boehringer Ingelheim Investigational Site
city: Augsburg
country: Germany
facility: 205.452.49161 Boehringer Ingelheim Investigational Site
city: Backnang
country: Germany
facility: 205.452.49001 Boehringer Ingelheim Investigational Site
city: Bad Kissingen
country: Germany
facility: 205.452.49173 Boehringer Ingelheim Investigational Site
city: Bad Lippspringe
country: Germany
facility: 205.452.49134 Boehringer Ingelheim Investigational Site
city: Bad Neustadt
country: Germany
facility: 205.452.49082 Boehringer Ingelheim Investigational Site
city: Bad Wörishofen
country: Germany
facility: 205.452.49058 Boehringer Ingelheim Investigational Site
city: Bamberg
country: Germany
facility: 205.452.49145 Boehringer Ingelheim Investigational Site
city: Bensheim
country: Germany
facility: 205.452.49072 Boehringer Ingelheim Investigational Site
city: Bergisch Gladbach
country: Germany
facility: 205.452.49048 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49006 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49016 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49028 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49031 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49054 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49064 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49066 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49068 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49102 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49135 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49138 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49157 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49167 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49175 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 205.452.49180 Boehringer Ingelheim Investigational Site
city: Bonn
country: Germany
facility: 205.452.49037 Boehringer Ingelheim Investigational Site
city: Bonn
country: Germany
facility: 205.452.49118 Boehringer Ingelheim Investigational Site
city: Brake
country: Germany
facility: 205.452.49083 Boehringer Ingelheim Investigational Site
city: Bruchsal
country: Germany
facility: 205.452.49040 Boehringer Ingelheim Investigational Site
city: Celle
country: Germany
facility: 205.452.49089 Boehringer Ingelheim Investigational Site
city: Cottbus
country: Germany
facility: 205.452.49143 Boehringer Ingelheim Investigational Site
city: Deggendorf
country: Germany
facility: 205.452.49119 Boehringer Ingelheim Investigational Site
city: Dillingen
country: Germany
facility: 205.452.49151 Boehringer Ingelheim Investigational Site
city: Donaueschingen
country: Germany
facility: 205.452.49117 Boehringer Ingelheim Investigational Site
city: Dortmund
country: Germany
facility: 205.452.49015 Boehringer Ingelheim Investigational Site
city: Düren
country: Germany
facility: 205.452.49008 Boehringer Ingelheim Investigational Site
city: Emden
country: Germany
facility: 205.452.49098 Boehringer Ingelheim Investigational Site
city: Engelskirchen
country: Germany
facility: 205.452.49003 Boehringer Ingelheim Investigational Site
city: Ense
country: Germany
facility: 205.452.49024 Boehringer Ingelheim Investigational Site
city: Essen
country: Germany
facility: 205.452.49168 Boehringer Ingelheim Investigational Site
city: Forchheim
country: Germany
facility: 205.452.49104 Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: 205.452.49070 Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: 205.452.49147 Boehringer Ingelheim Investigational Site
city: Fulda
country: Germany
facility: 205.452.49137 Boehringer Ingelheim Investigational Site
city: Föhren
country: Germany
facility: 205.452.49133 Boehringer Ingelheim Investigational Site
city: Gelnhausen
country: Germany
facility: 205.452.49107 Boehringer Ingelheim Investigational Site
city: Gütersloh
country: Germany
facility: 205.452.49032 Boehringer Ingelheim Investigational Site
city: Hagen
country: Germany
facility: 205.452.49026 Boehringer Ingelheim Investigational Site
city: Hagen
country: Germany
facility: 205.452.49041 Boehringer Ingelheim Investigational Site
city: Hamburg
country: Germany
facility: 205.452.49044 Boehringer Ingelheim Investigational Site
city: Hamburg
country: Germany
facility: 205.452.49061 Boehringer Ingelheim Investigational Site
city: Hamburg
country: Germany
facility: 205.452.49080 Boehringer Ingelheim Investigational Site
city: Hannover
country: Germany
facility: 205.452.49038 Boehringer Ingelheim Investigational Site
city: Hannover
country: Germany
facility: 205.452.49052 Boehringer Ingelheim Investigational Site
city: Hannover
country: Germany
facility: 205.452.49094 Boehringer Ingelheim Investigational Site
city: Heidelberg
country: Germany
facility: 205.452.49181 Boehringer Ingelheim Investigational Site
city: Heilbronn
country: Germany
facility: 205.452.49116 Boehringer Ingelheim Investigational Site
city: Hemmingen
country: Germany
facility: 205.452.49022 Boehringer Ingelheim Investigational Site
city: Höchstädt
country: Germany
facility: 205.452.49007 Boehringer Ingelheim Investigational Site
city: Ingelheim
country: Germany
facility: 205.452.49136 Boehringer Ingelheim Investigational Site
city: Karlsruhe
country: Germany
facility: 205.452.49159 Boehringer Ingelheim Investigational Site
city: Kassel
country: Germany
facility: 205.452.49027 Boehringer Ingelheim Investigational Site
city: Kaufbeuren
country: Germany
facility: 205.452.49105 Boehringer Ingelheim Investigational Site
city: Koblenz
country: Germany
facility: 205.452.49101 Boehringer Ingelheim Investigational Site
city: Käbschütztal-Krögis
country: Germany
facility: 205.452.49047 Boehringer Ingelheim Investigational Site
city: Köln
country: Germany
facility: 205.452.49146 Boehringer Ingelheim Investigational Site
city: Landsberg am Lech
country: Germany
facility: 205.452.49114 Boehringer Ingelheim Investigational Site
city: Langen
country: Germany
facility: 205.452.49169 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 205.452.49017 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 205.452.49035 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 205.452.49113 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 205.452.49139 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 205.452.49172 Boehringer Ingelheim Investigational Site
city: Leonberg
country: Germany
facility: 205.452.49110 Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: 205.452.49088 Boehringer Ingelheim Investigational Site
city: Marburg
country: Germany
facility: 205.452.49108 Boehringer Ingelheim Investigational Site
city: Marburg
country: Germany
facility: 205.452.49122 Boehringer Ingelheim Investigational Site
city: Minden
country: Germany
facility: 205.452.49055 Boehringer Ingelheim Investigational Site
city: München
country: Germany
facility: 205.452.49025 Boehringer Ingelheim Investigational Site
city: München
country: Germany
facility: 205.452.49131 Boehringer Ingelheim Investigational Site
city: Neumünster
country: Germany
facility: 205.452.49023 Boehringer Ingelheim Investigational Site
city: Neuruppin
country: Germany
facility: 205.452.49132 Boehringer Ingelheim Investigational Site
city: Neuwied
country: Germany
facility: 205.452.49045 Boehringer Ingelheim Investigational Site
city: Oranienburg
country: Germany
facility: 205.452.49062 Boehringer Ingelheim Investigational Site
city: Oschersleben
country: Germany
facility: 205.452.49124 Boehringer Ingelheim Investigational Site
city: Paderborn
country: Germany
facility: 205.452.49019 Boehringer Ingelheim Investigational Site
city: Potsdam
country: Germany
facility: 205.452.49053 Boehringer Ingelheim Investigational Site
city: Potsdam
country: Germany
facility: 205.452.49076 Boehringer Ingelheim Investigational Site
city: Radebeul
country: Germany
facility: 205.452.49049 Boehringer Ingelheim Investigational Site
city: Rathenow
country: Germany
facility: 205.452.49056 Boehringer Ingelheim Investigational Site
city: Raubach
country: Germany
facility: 205.452.49009 Boehringer Ingelheim Investigational Site
city: Rehau
country: Germany
facility: 205.452.49002 Boehringer Ingelheim Investigational Site
city: Reinfeld
country: Germany
facility: 205.452.49142 Boehringer Ingelheim Investigational Site
city: Rhaunen
country: Germany
facility: 205.452.49030 Boehringer Ingelheim Investigational Site
city: Rheine
country: Germany
facility: 205.452.49184 Boehringer Ingelheim Investigational Site
city: Rodgau-Dudenhofen
country: Germany
facility: 205.452.49077 Boehringer Ingelheim Investigational Site
city: Rüsselsheim
country: Germany
facility: 205.452.49021 Boehringer Ingelheim Investigational Site
city: Rüsselsheim
country: Germany
facility: 205.452.49091 Boehringer Ingelheim Investigational Site
city: Saarlouis
country: Germany
facility: 205.452.49042 Boehringer Ingelheim Investigational Site
city: Schwetzingen
country: Germany
facility: 205.452.49034 Boehringer Ingelheim Investigational Site
city: Solingen
country: Germany
facility: 205.452.49013 Boehringer Ingelheim Investigational Site
city: Solingen
country: Germany
facility: 205.452.49057 Boehringer Ingelheim Investigational Site
city: Tübingen
country: Germany
facility: 205.452.49078 Boehringer Ingelheim Investigational Site
city: Ulm
country: Germany
facility: 205.452.49099 Boehringer Ingelheim Investigational Site
city: Wallerfing
country: Germany
facility: 205.452.49043 Boehringer Ingelheim Investigational Site
city: Wardenburg
country: Germany
facility: 205.452.49067 Boehringer Ingelheim Investigational Site
city: Warendorf
country: Germany
facility: 205.452.49165 Boehringer Ingelheim Investigational Site
city: Weinheim
country: Germany
facility: 205.452.49051 Boehringer Ingelheim Investigational Site
city: Weyhe
country: Germany
facility: 205.452.49127 Boehringer Ingelheim Investigational Site
city: Wiesloch
country: Germany
facility: 205.452.49092 Boehringer Ingelheim Investigational Site
city: Witten
country: Germany
facility: 205.452.49018 Boehringer Ingelheim Investigational Site
city: Witten
country: Germany
facility: 205.452.49029 Boehringer Ingelheim Investigational Site
city: Wolfsburg
country: Germany
facility: 205.452.49095 Boehringer Ingelheim Investigational Site
city: Zerbst
country: Germany
facility: 205.452.49060 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 205.452.30002 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 205.452.30003 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 205.452.30008 Boehringer Ingelheim Investigational Site
city: Heraklion
country: Greece
facility: 205.452.30001 Boehringer Ingelheim Investigational Site
city: Kalamaria
country: Greece
facility: 205.452.30007 Boehringer Ingelheim Investigational Site
city: Kavala
country: Greece
facility: 205.452.30010 Boehringer Ingelheim Investigational Site
city: Lamia
country: Greece
facility: 205.452.30012 Boehringer Ingelheim Investigational Site
city: Nafplio
country: Greece
facility: 205.452.30005 Boehringer Ingelheim Investigational Site
city: Rethymno
country: Greece
facility: 205.452.30011 Boehringer Ingelheim Investigational Site
city: Serres
country: Greece
facility: 205.452.30006 Boehringer Ingelheim Investigational Site
city: Thessaloniki
country: Greece
facility: 205.452.30004 Boehringer Ingelheim Investigational Site
city: Thessaloniki
country: Greece
facility: 205.452.30009 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 205.452.50205 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 205.452.50206 Boehringer Ingelheim Investigational Site
city: Nivel 12
country: Guatemala
facility: 205.452.50203 Boehringer Ingelheim Investigational Site
city: Nivel Guatemala
country: Guatemala
facility: 205.452.50201 Boehringer Ingelheim Investigational Site
city: Nivel Guatemala
country: Guatemala
facility: 205.452.50202 Boehringer Ingelheim Investigational Site
city: Nivel Guatemala
country: Guatemala
facility: 205.452.50204 Boehringer Ingelheim Investigational Site
city: Quetzaltenango
country: Guatemala
facility: 205.452.50207 Boehringer Ingelheim Investigational Site
city: Baja
country: Hungary
facility: 205.452.36005 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 205.452.36004 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 205.452.36016 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 205.452.36030 Boehringer Ingelheim Investigational Site
city: Debrecen
country: Hungary
facility: 205.452.36007 Boehringer Ingelheim Investigational Site
city: Debrecen
country: Hungary
facility: 205.452.36013 Boehringer Ingelheim Investigational Site
city: Debrecen
country: Hungary
facility: 205.452.36015 Boehringer Ingelheim Investigational Site
city: Deszk
country: Hungary
facility: 205.452.36029 Boehringer Ingelheim Investigational Site
city: Dombovar
country: Hungary
facility: 205.452.36026 Boehringer Ingelheim Investigational Site
city: Erd
country: Hungary
facility: 205.452.36003 Boehringer Ingelheim Investigational Site
city: Farkasgyepü
country: Hungary
facility: 205.452.36008 Boehringer Ingelheim Investigational Site
city: Györ
country: Hungary
facility: 205.452.36020 Boehringer Ingelheim Investigational Site
city: Hajduböszörmeny
country: Hungary
facility: 205.452.36012 Boehringer Ingelheim Investigational Site
city: Hodmezovasarhely
country: Hungary
facility: 205.452.36023 Boehringer Ingelheim Investigational Site
city: Kaposvar
country: Hungary
facility: 205.452.36010 Boehringer Ingelheim Investigational Site
city: Kapuvar
country: Hungary
facility: 205.452.36018 Boehringer Ingelheim Investigational Site
city: Kecskemet
country: Hungary
facility: 205.452.36002 Boehringer Ingelheim Investigational Site
city: Makó
country: Hungary
facility: 205.452.36001 Boehringer Ingelheim Investigational Site
city: Mohacs
country: Hungary
facility: 205.452.36006 Boehringer Ingelheim Investigational Site
city: Mosonmagyarovar
country: Hungary
facility: 205.452.36022 Boehringer Ingelheim Investigational Site
city: Nagykanizsa
country: Hungary
facility: 205.452.36027 Boehringer Ingelheim Investigational Site
city: Nyiregyhaza
country: Hungary
facility: 205.452.36014 Boehringer Ingelheim Investigational Site
city: Pecs
country: Hungary
facility: 205.452.36009 Boehringer Ingelheim Investigational Site
city: Pecs
country: Hungary
facility: 205.452.36011 Boehringer Ingelheim Investigational Site
city: Siófok
country: Hungary
facility: 205.452.36028 Boehringer Ingelheim Investigational Site
city: Szarvas
country: Hungary
facility: 205.452.36021 Boehringer Ingelheim Investigational Site
city: Szeged
country: Hungary
facility: 205.452.36017 Boehringer Ingelheim Investigational Site
city: Tatabanya
country: Hungary
facility: 205.452.36024 Boehringer Ingelheim Investigational Site
city: Törökbálint
country: Hungary
facility: 205.452.36019 Boehringer Ingelheim Investigational Site
city: Törökbálint
country: Hungary
facility: 205.452.36025 Boehringer Ingelheim Investigational Site
city: Ahmedabad
country: India
facility: 205.452.91017 Boehringer Ingelheim Investigational Site
city: Chennai
country: India
facility: 205.452.91018 Boehringer Ingelheim Investigational Site
city: Coimbatore
country: India
facility: 205.452.91001 Boehringer Ingelheim Investigational Site
city: Coimbatore
country: India
facility: 205.452.91002 Boehringer Ingelheim Investigational Site
city: Dadar(East)
country: India
facility: 205.452.91014 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 205.452.91005 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 205.452.91009 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 205.452.91004 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 205.452.91007 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 205.452.91015 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 205.452.91016 Boehringer Ingelheim Investigational Site
city: Karnataka
country: India
facility: 205.452.91008 Boehringer Ingelheim Investigational Site
city: Maharashtra
country: India
facility: 205.452.91006 Boehringer Ingelheim Investigational Site
city: Maharastra
country: India
facility: 205.452.91003 Boehringer Ingelheim Investigational Site
city: Punjab
country: India
facility: 205.452.91011 Boehringer Ingelheim Investigational Site
city: Co. Cork
country: Ireland
facility: 205.452.35307 Boehringer Ingelheim Investigational Site
city: Co. Tipperary
country: Ireland
facility: 205.452.35306 Boehringer Ingelheim Investigational Site
city: Co. Wexford
country: Ireland
facility: 205.452.35305 Boehringer Ingelheim Investigational Site
city: Dublin 24
country: Ireland
facility: 205.452.35301 Boehringer Ingelheim Investigational Site
city: Dublin
country: Ireland
facility: 205.452.35302 Boehringer Ingelheim Investigational Site
city: Limerick
country: Ireland
facility: 205.452.35303 Boehringer Ingelheim Investigational Site
city: Limerick
country: Ireland
facility: 205.452.35308 Boehringer Ingelheim Investigational Site
city: Offaly
country: Ireland
facility: 205.452.35304 Boehringer Ingelheim Investigational Site
city: Ashkelon
country: Israel
facility: 205.452.97207 Boehringer Ingelheim Investigational Site
city: Beer Sheva
country: Israel
facility: 205.452.97204 Boehringer Ingelheim Investigational Site
city: Haifa
country: Israel
facility: 205.452.97208 Boehringer Ingelheim Investigational Site
city: Jerusalem
country: Israel
facility: 205.452.97202 Boehringer Ingelheim Investigational Site
city: Kfar Saba
country: Israel
facility: 205.452.97206 Boehringer Ingelheim Investigational Site
city: Petach Tikva
country: Israel
facility: 205.452.97203 Boehringer Ingelheim Investigational Site
city: Rehovot
country: Israel
facility: 205.452.97201 Boehringer Ingelheim Investigational Site
city: Tel-Aviv
country: Israel
facility: 205.452.97205 Boehringer Ingelheim Investigational Site
city: Arenzano (ge)
country: Italy
facility: 205.452.39003 Boehringer Ingelheim Investigational Site
city: Ascoli Piceno
country: Italy
facility: 205.452.39019 Boehringer Ingelheim Investigational Site
city: Avellino
country: Italy
facility: 205.452.39016 Boehringer Ingelheim Investigational Site
city: Benevento
country: Italy
facility: 205.452.39007 Boehringer Ingelheim Investigational Site
city: Brescia
country: Italy
facility: 205.452.39024 Boehringer Ingelheim Investigational Site
city: Busto Arsizio (va)
country: Italy
facility: 205.452.39029 Boehringer Ingelheim Investigational Site
city: Cagliari
country: Italy
facility: 205.452.39011 Boehringer Ingelheim Investigational Site
city: Cagliari
country: Italy
facility: 205.452.39013 Boehringer Ingelheim Investigational Site
city: Cagliari
country: Italy
facility: 205.452.39020 Boehringer Ingelheim Investigational Site
city: Catanzaro
country: Italy
facility: 205.452.39015 Boehringer Ingelheim Investigational Site
city: Chieti Scalo
country: Italy
facility: 205.452.39006 Boehringer Ingelheim Investigational Site
city: Firenze
country: Italy
facility: 205.452.39001 Boehringer Ingelheim Investigational Site
city: Monza
country: Italy
facility: 205.452.39021 Boehringer Ingelheim Investigational Site
city: Napoli
country: Italy
facility: 205.452.39014 Boehringer Ingelheim Investigational Site
city: Orbassano (to)
country: Italy
facility: 205.452.39012 Boehringer Ingelheim Investigational Site
city: Orbassano (to)
country: Italy
facility: 205.452.39026 Boehringer Ingelheim Investigational Site
city: Palermo
country: Italy
facility: 205.452.39010 Boehringer Ingelheim Investigational Site
city: Parma
country: Italy
facility: 205.452.39005 Boehringer Ingelheim Investigational Site
city: Perugia
country: Italy
facility: 205.452.39009 Boehringer Ingelheim Investigational Site
city: Prato
country: Italy
facility: 205.452.39002 Boehringer Ingelheim Investigational Site
city: Reggio Emilia
country: Italy
facility: 205.452.39030 Boehringer Ingelheim Investigational Site
city: Roma
country: Italy
facility: 205.452.39004 Boehringer Ingelheim Investigational Site
city: Roma
country: Italy
facility: 205.452.39017 Boehringer Ingelheim Investigational Site
city: Roma
country: Italy
facility: 205.452.39027 Boehringer Ingelheim Investigational Site
city: Treviso
country: Italy
facility: 205.452.39023 Boehringer Ingelheim Investigational Site
city: Bucheon
country: Korea, Republic of
facility: 205.452.82008 Boehringer Ingelheim Investigational Site
city: Busan
country: Korea, Republic of
facility: 205.452.82002 Boehringer Ingelheim Investigational Site
city: Busan
country: Korea, Republic of
facility: 205.452.82012 Boehringer Ingelheim Investigational Site
city: Daegu
country: Korea, Republic of
facility: 205.452.82010 Boehringer Ingelheim Investigational Site
city: Daejoen
country: Korea, Republic of
facility: 205.452.82016 Boehringer Ingelheim Investigational Site
city: Gangwon-Do
country: Korea, Republic of
facility: 205.452.82009 Boehringer Ingelheim Investigational Site
city: Goyang
country: Korea, Republic of
facility: 205.452.82017 Boehringer Ingelheim Investigational Site
city: Gwangju
country: Korea, Republic of
facility: 205.452.82004 Boehringer Ingelheim Investigational Site
city: Incheon
country: Korea, Republic of
facility: 205.452.82005 Boehringer Ingelheim Investigational Site
city: Jeonju
country: Korea, Republic of
facility: 205.452.82020 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82001 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82003 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82006 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82007 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82011 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82013 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82014 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82015 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 205.452.82018 Boehringer Ingelheim Investigational Site
city: Uijeongbu
country: Korea, Republic of
facility: 205.452.82019 Boehringer Ingelheim Investigational Site
city: Daugavpils
country: Latvia
facility: 205.452.37106 Boehringer Ingelheim Investigational Site
city: Daugavpils
country: Latvia
facility: 205.452.37107 Boehringer Ingelheim Investigational Site
city: Daugavpils
country: Latvia
facility: 205.452.37108 Boehringer Ingelheim Investigational Site
city: Kraslava
country: Latvia
facility: 205.452.37102 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 205.452.37104 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 205.452.37105 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 205.452.37109 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 205.452.37110 Boehringer Ingelheim Investigational Site
city: Talsi
country: Latvia
facility: 205.452.37101 Boehringer Ingelheim Investigational Site
city: Valmiera
country: Latvia
facility: 205.452.37103 Boehringer Ingelheim Investigational Site
city: Alytus
country: Lithuania
facility: 205.452.37003 Boehringer Ingelheim Investigational Site
city: Kaunas
country: Lithuania
facility: 205.452.37001 Boehringer Ingelheim Investigational Site
city: Kaunas
country: Lithuania
facility: 205.452.37002 Boehringer Ingelheim Investigational Site
city: Klaipeda
country: Lithuania
facility: 205.452.37005 Boehringer Ingelheim Investigational Site
city: Siauliai
country: Lithuania
facility: 205.452.37007 Boehringer Ingelheim Investigational Site
city: Utena
country: Lithuania
facility: 205.452.37011 Boehringer Ingelheim Investigational Site
city: Vilnius
country: Lithuania
facility: 205.452.37004 Boehringer Ingelheim Investigational Site
city: Vilnius
country: Lithuania
facility: 205.452.37008 Boehringer Ingelheim Investigational Site
city: Vilnius
country: Lithuania
facility: 205.452.37010 Boehringer Ingelheim Investigational Site
city: Johor Bahru
country: Malaysia
facility: 205.452.60006 Boehringer Ingelheim Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: 205.452.60001 Boehringer Ingelheim Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: 205.452.60002 Boehringer Ingelheim Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: 205.452.60004 Boehringer Ingelheim Investigational Site
city: Pahang
country: Malaysia
facility: 205.452.60008 Boehringer Ingelheim Investigational Site
city: Sarawak
country: Malaysia
facility: 205.452.60005 Boehringer Ingelheim Investigational Site
city: Selangor
country: Malaysia
facility: 205.452.60009 Boehringer Ingelheim Investigational Site
city: Terengganu
country: Malaysia
facility: 205.452.60007 Boehringer Ingelheim Investigational Site
city: Aguascalientes
country: Mexico
facility: 205.452.52004 Boehringer Ingelheim Investigational Site
city: Distrito Federal
country: Mexico
facility: 205.452.52007 Boehringer Ingelheim Investigational Site
city: Guadalajara
country: Mexico
facility: 205.452.52005 Boehringer Ingelheim Investigational Site
city: Monte Rey
country: Mexico
facility: 205.452.52002 Boehringer Ingelheim Investigational Site
city: México
country: Mexico
facility: 205.452.52001 Boehringer Ingelheim Investigational Site
city: Zona Río
country: Mexico
facility: 205.452.52003 Boehringer Ingelheim Investigational Site
city: Almere
country: Netherlands
facility: 205.452.31001 Boehringer Ingelheim Investigational Site
city: Andijk
country: Netherlands
facility: 205.452.31008 Boehringer Ingelheim Investigational Site
city: Beek En Donk
country: Netherlands
facility: 205.452.31012 Boehringer Ingelheim Investigational Site
city: Beek
country: Netherlands
facility: 205.452.31002 Boehringer Ingelheim Investigational Site
city: Ermelo
country: Netherlands
facility: 205.452.31003 Boehringer Ingelheim Investigational Site
city: Hoogwoud
country: Netherlands
facility: 205.452.31010 Boehringer Ingelheim Investigational Site
city: Nijverdal
country: Netherlands
facility: 205.452.31011 Boehringer Ingelheim Investigational Site
city: Oude Pekela
country: Netherlands
facility: 205.452.31007 Boehringer Ingelheim Investigational Site
city: Roelofarendsveen
country: Netherlands
facility: 205.452.31005 Boehringer Ingelheim Investigational Site
city: Christchurch
country: New Zealand
facility: 205.452.64004 Boehringer Ingelheim Investigational Site
city: Dunedin
country: New Zealand
facility: 205.452.64003 Boehringer Ingelheim Investigational Site
city: Newtown Wellington NZ
country: New Zealand
facility: 205.452.64002 Boehringer Ingelheim Investigational Site
city: Tauranga
country: New Zealand
facility: 205.452.64001 Boehringer Ingelheim Investigational Site
city: Drammen
country: Norway
facility: 205.452.47008 Boehringer Ingelheim Investigational Site
city: Fredrikstad
country: Norway
facility: 205.452.47009 Boehringer Ingelheim Investigational Site
city: Hønefoss
country: Norway
facility: 205.452.47001 Boehringer Ingelheim Investigational Site
city: Kløfta
country: Norway
facility: 205.452.47010 Boehringer Ingelheim Investigational Site
city: Kolbjørnsvik
country: Norway
facility: 205.452.47007 Boehringer Ingelheim Investigational Site
city: Løvenstad
country: Norway
facility: 205.452.47005 Boehringer Ingelheim Investigational Site
city: Oslo
country: Norway
facility: 205.452.47002 Boehringer Ingelheim Investigational Site
city: Oslo
country: Norway
facility: 205.452.47003 Boehringer Ingelheim Investigational Site
city: Oslo
country: Norway
facility: 205.452.47011 Boehringer Ingelheim Investigational Site
city: Sandvika
country: Norway
facility: 205.452.47012 Boehringer Ingelheim Investigational Site
city: Svelvik
country: Norway
facility: 205.452.47004 Boehringer Ingelheim Investigational Site
city: Trollåsen
country: Norway
facility: 205.452.47006 Boehringer Ingelheim Investigational Site
city: Carrasquilla
country: Panama
facility: 205.452.50703 Boehringer Ingelheim Investigational Site
city: Marbella
country: Panama
facility: 205.452.50701 Boehringer Ingelheim Investigational Site
city: Marbella
country: Panama
facility: 205.452.50702 Boehringer Ingelheim Investigational Site
city: Bellavista
country: Peru
facility: 205.452.51002 Boehringer Ingelheim Investigational Site
city: Cusco
country: Peru
facility: 205.452.51003 Boehringer Ingelheim Investigational Site
city: Jesús Maria
country: Peru
facility: 205.452.51004 Boehringer Ingelheim Investigational Site
city: Jesús María
country: Peru
facility: 205.452.51007 Boehringer Ingelheim Investigational Site
city: Lima
country: Peru
facility: 205.452.51005 Boehringer Ingelheim Investigational Site
city: San Isidro
country: Peru
facility: 205.452.51001 Boehringer Ingelheim Investigational Site
city: San Martin de Porres
country: Peru
facility: 205.452.51006 Boehringer Ingelheim Investigational Site
city: Cavite City
country: Philippines
facility: 205.452.63004 Boehringer Ingelheim Investigational Site
city: Davao City
country: Philippines
facility: 205.452.63002 Boehringer Ingelheim Investigational Site
city: Iloilo City
country: Philippines
facility: 205.452.63003 Boehringer Ingelheim Investigational Site
city: Iloilo City
country: Philippines
facility: 205.452.63006 Boehringer Ingelheim Investigational Site
city: Manila
country: Philippines
facility: 205.452.63001 Boehringer Ingelheim Investigational Site
city: Manila
country: Philippines
facility: 205.452.63008 Boehringer Ingelheim Investigational Site
city: Quezon City
country: Philippines
facility: 205.452.63005 Boehringer Ingelheim Investigational Site
city: Quezon City
country: Philippines
facility: 205.452.63007 Boehringer Ingelheim Investigational Site
city: Babice
country: Poland
facility: 205.452.48031 Boehringer Ingelheim Investigational Site
city: Bialystok
country: Poland
facility: 205.452.48003 Boehringer Ingelheim Investigational Site
city: Bialystok
country: Poland
facility: 205.452.48011 Boehringer Ingelheim Investigational Site
city: Bydgoszcz
country: Poland
facility: 205.452.48014 Boehringer Ingelheim Investigational Site
city: Checiny
country: Poland
facility: 205.452.48008 Boehringer Ingelheim Investigational Site
city: Gdansk
country: Poland
facility: 205.452.48016 Boehringer Ingelheim Investigational Site
city: Gdynia
country: Poland
facility: 205.452.48019 Boehringer Ingelheim Investigational Site
city: Gorzow Wlkp
country: Poland
facility: 205.452.48037 Boehringer Ingelheim Investigational Site
city: Ilawa
country: Poland
facility: 205.452.48015 Boehringer Ingelheim Investigational Site
city: Katowice
country: Poland
facility: 205.452.48033 Boehringer Ingelheim Investigational Site
city: Katowice
country: Poland
facility: 205.452.48039 Boehringer Ingelheim Investigational Site
city: Katowice
country: Poland
facility: 205.452.48044 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 205.452.48009 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 205.452.48021 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 205.452.48029 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 205.452.48030 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 205.452.48048 Boehringer Ingelheim Investigational Site
city: Libiaz
country: Poland
facility: 205.452.48043 Boehringer Ingelheim Investigational Site
city: Lodz
country: Poland
facility: 205.452.48002 Boehringer Ingelheim Investigational Site
city: Lodz
country: Poland
facility: 205.452.48051 Boehringer Ingelheim Investigational Site
city: Lodz
country: Poland
facility: 205.452.48056 Boehringer Ingelheim Investigational Site
city: Lodz
country: Poland
facility: 205.452.48059 Boehringer Ingelheim Investigational Site
city: Olsztyn
country: Poland
facility: 205.452.48018 Boehringer Ingelheim Investigational Site
city: Ostrow Wielkopolska
country: Poland
facility: 205.452.48025 Boehringer Ingelheim Investigational Site
city: Piaseczno
country: Poland
facility: 205.452.48012 Boehringer Ingelheim Investigational Site
city: Piaseczno
country: Poland
facility: 205.452.48040 Boehringer Ingelheim Investigational Site
city: Poznan
country: Poland
facility: 205.452.48026 Boehringer Ingelheim Investigational Site
city: Poznan
country: Poland
facility: 205.452.48027 Boehringer Ingelheim Investigational Site
city: Poznan
country: Poland
facility: 205.452.48058 Boehringer Ingelheim Investigational Site
city: Rokietnica
country: Poland
facility: 205.452.48060 Boehringer Ingelheim Investigational Site
city: Skierniewice
country: Poland
facility: 205.452.48001 Boehringer Ingelheim Investigational Site
city: Slawkow
country: Poland
facility: 205.452.48032 Boehringer Ingelheim Investigational Site
city: Szczecin
country: Poland
facility: 205.452.48036 Boehringer Ingelheim Investigational Site
city: Tarnow
country: Poland
facility: 205.452.48045 Boehringer Ingelheim Investigational Site
city: Tczew
country: Poland
facility: 205.452.48057 Boehringer Ingelheim Investigational Site
city: Torun
country: Poland
facility: 205.452.48004 Boehringer Ingelheim Investigational Site
city: Tranow
country: Poland
facility: 205.452.48007 Boehringer Ingelheim Investigational Site
city: Turek
country: Poland
facility: 205.452.48053 Boehringer Ingelheim Investigational Site
city: Warsaw
country: Poland
facility: 205.452.48034 Boehringer Ingelheim Investigational Site
city: Warszawa
country: Poland
facility: 205.452.48042 Boehringer Ingelheim Investigational Site
city: Warszawa
country: Poland
facility: 205.452.48049 Boehringer Ingelheim Investigational Site
city: Wolomin
country: Poland
facility: 205.452.48017 Boehringer Ingelheim Investigational Site
city: Wroclaw
country: Poland
facility: 205.452.48006 Boehringer Ingelheim Investigational Site
city: Wroclaw
country: Poland
facility: 205.452.48028 Boehringer Ingelheim Investigational Site
city: Wroclaw
country: Poland
facility: 205.452.48035 Boehringer Ingelheim Investigational Site
city: Wroclaw
country: Poland
facility: 205.452.48038 Boehringer Ingelheim Investigational Site
city: Zakopane
country: Poland
facility: 205.452.48022 Boehringer Ingelheim Investigational Site
city: Amadora
country: Portugal
facility: 205.452.35103 Boehringer Ingelheim Investigational Site
city: Coimbra
country: Portugal
facility: 205.452.35102 Boehringer Ingelheim Investigational Site
city: Lisboa
country: Portugal
facility: 205.452.35107 Boehringer Ingelheim Investigational Site
city: Lisboa
country: Portugal
facility: 205.452.35108 Boehringer Ingelheim Investigational Site
city: Matosinhos
country: Portugal
facility: 205.452.35101 Boehringer Ingelheim Investigational Site
city: Penafiel
country: Portugal
facility: 205.452.35105 Boehringer Ingelheim Investigational Site
city: Vila Nova de Gaia
country: Portugal
facility: 205.452.35106 Boehringer Ingelheim Investigational Site
city: Viseu
country: Portugal
facility: 205.452.35104 Boehringer Ingelheim Investigational Site
city: Ponce
country: Puerto Rico
facility: 205.452.01177 Boehringer Ingelheim Investigational Site
city: San Juan
country: Puerto Rico
facility: 205.452.01162 Boehringer Ingelheim Investigational Site
city: Brasov
country: Romania
facility: 205.452.40008 Boehringer Ingelheim Investigational Site
city: Brasov
country: Romania
facility: 205.452.40012 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 205.452.40001 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 205.452.40003 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 205.452.40004 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 205.452.40007 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 205.452.40009 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 205.452.40013 Boehringer Ingelheim Investigational Site
city: Bucuresti
country: Romania
facility: 205.452.40002 Boehringer Ingelheim Investigational Site
city: Constanta
country: Romania
facility: 205.452.40011 Boehringer Ingelheim Investigational Site
city: Craiova
country: Romania
facility: 205.452.40006 Boehringer Ingelheim Investigational Site
city: Arkhangelsk
country: Russian Federation
facility: 205.452.07030 Boehringer Ingelheim Investigational Site
city: Barnaul
country: Russian Federation
facility: 205.452.07049 Boehringer Ingelheim Investigational Site
city: Barnaul
country: Russian Federation
facility: 205.452.07054 Boehringer Ingelheim Investigational Site
city: Chelyabinsk
country: Russian Federation
facility: 205.452.07053 Boehringer Ingelheim Investigational Site
city: Ekaterinburg
country: Russian Federation
facility: 205.452.07031 Boehringer Ingelheim Investigational Site
city: Gatchina (Leningradskaya oblast)
country: Russian Federation
facility: 205.452.07038 Boehringer Ingelheim Investigational Site
city: Irkutsk
country: Russian Federation
facility: 205.452.07036 Boehringer Ingelheim Investigational Site
city: Ivanovo
country: Russian Federation
facility: 205.452.07001 Boehringer Ingelheim Investigational Site
city: Kaliningrad
country: Russian Federation
facility: 205.452.07023 Boehringer Ingelheim Investigational Site
city: Kazan
country: Russian Federation
facility: 205.452.07003 Boehringer Ingelheim Investigational Site
city: Kazan
country: Russian Federation
facility: 205.452.07005 Boehringer Ingelheim Investigational Site
city: Kazan
country: Russian Federation
facility: 205.452.07007 Boehringer Ingelheim Investigational Site
city: Kemerovo
country: Russian Federation
facility: 205.452.07048 Boehringer Ingelheim Investigational Site
city: Kemerovo
country: Russian Federation
facility: 205.452.07060 Boehringer Ingelheim Investigational Site
city: Kirov
country: Russian Federation
facility: 205.452.07059 Boehringer Ingelheim Investigational Site
city: Krasnodar
country: Russian Federation
facility: 205.452.07009 Boehringer Ingelheim Investigational Site
city: Krasnodar
country: Russian Federation
facility: 205.452.07010 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07013 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07020 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07021 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07026 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07027 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07028 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07029 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07043 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 205.452.07045 Boehringer Ingelheim Investigational Site
city: Murmansk
country: Russian Federation
facility: 205.452.07004 Boehringer Ingelheim Investigational Site
city: Nizhniy Novgorod
country: Russian Federation
facility: 205.452.07055 Boehringer Ingelheim Investigational Site
city: Nizhny Novgorod
country: Russian Federation
facility: 205.452.07051 Boehringer Ingelheim Investigational Site
city: Novosibirsk
country: Russian Federation
facility: 205.452.07037 Boehringer Ingelheim Investigational Site
city: Novosibirsk
country: Russian Federation
facility: 205.452.07040 Boehringer Ingelheim Investigational Site
city: Novosibirsk
country: Russian Federation
facility: 205.452.07042 Boehringer Ingelheim Investigational Site
city: Penza
country: Russian Federation
facility: 205.452.07041 Boehringer Ingelheim Investigational Site
city: Pskov
country: Russian Federation
facility: 205.452.07050 Boehringer Ingelheim Investigational Site
city: Rostov-na-Donu
country: Russian Federation
facility: 205.452.07015 Boehringer Ingelheim Investigational Site
city: Rostov-on-Don
country: Russian Federation
facility: 205.452.07016 Boehringer Ingelheim Investigational Site
city: Ryazan
country: Russian Federation
facility: 205.452.07039 Boehringer Ingelheim Investigational Site
city: Samara
country: Russian Federation
facility: 205.452.07034 Boehringer Ingelheim Investigational Site
city: Saratov
country: Russian Federation
facility: 205.452.07047 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07002 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07006 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07011 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07014 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07017 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07018 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07022 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07024 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07025 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07033 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07046 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 205.452.07052 Boehringer Ingelheim Investigational Site
city: Tomsk
country: Russian Federation
facility: 205.452.07032 Boehringer Ingelheim Investigational Site
city: Tomsk
country: Russian Federation
facility: 205.452.07035 Boehringer Ingelheim Investigational Site
city: Tomsk
country: Russian Federation
facility: 205.452.07057 Boehringer Ingelheim Investigational Site
city: Velikiy Novgorod
country: Russian Federation
facility: 205.452.07019 Boehringer Ingelheim Investigational Site
city: Yaroslavl
country: Russian Federation
facility: 205.452.07044 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 205.452.38103 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 205.452.38104 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 205.452.38106 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 205.452.38107 Boehringer Ingelheim Investigational Site
city: Kragujevac
country: Serbia
facility: 205.452.38102 Boehringer Ingelheim Investigational Site
city: Nis
country: Serbia
facility: 205.452.38105 Boehringer Ingelheim Investigational Site
city: Sremska Kamenica
country: Serbia
facility: 205.452.38101 Boehringer Ingelheim Investigational Site
city: Bardejov
country: Slovakia
facility: 205.452.42103 Boehringer Ingelheim Investigational Site
city: Bratislava
country: Slovakia
facility: 205.452.42107 Boehringer Ingelheim Investigational Site
city: Humenne
country: Slovakia
facility: 205.452.42102 Boehringer Ingelheim Investigational Site
city: Kosice
country: Slovakia
facility: 205.452.42105 Boehringer Ingelheim Investigational Site
city: Kosice
country: Slovakia
facility: 205.452.42111 Boehringer Ingelheim Investigational Site
city: Kosice
country: Slovakia
facility: 205.452.42113 Boehringer Ingelheim Investigational Site
city: Levice
country: Slovakia
facility: 205.452.42108 Boehringer Ingelheim Investigational Site
city: Martin
country: Slovakia
facility: 205.452.42109 Boehringer Ingelheim Investigational Site
city: Poprad
country: Slovakia
facility: 205.452.42112 Boehringer Ingelheim Investigational Site
city: Presov
country: Slovakia
facility: 205.452.42101 Boehringer Ingelheim Investigational Site
city: Rimavska Sobota
country: Slovakia
facility: 205.452.42104 Boehringer Ingelheim Investigational Site
city: Spisska Nova Ves
country: Slovakia
facility: 205.452.42106 Boehringer Ingelheim Investigational Site
city: Sturovo
country: Slovakia
facility: 205.452.42110 Boehringer Ingelheim Investigational Site
city: Amanzimtoti
country: South Africa
facility: 205.452.27013 Boehringer Ingelheim Investigational Site
city: Bellville
country: South Africa
facility: 205.452.27002 Boehringer Ingelheim Investigational Site
city: Bloemfontein
country: South Africa
facility: 205.452.27010 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 205.452.27001 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 205.452.27004 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 205.452.27008 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 205.452.27011 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 205.452.27012 Boehringer Ingelheim Investigational Site
city: Centurion
country: South Africa
facility: 205.452.27006 Boehringer Ingelheim Investigational Site
city: Durban
country: South Africa
facility: 205.452.27003 Boehringer Ingelheim Investigational Site
city: Johannesburg
country: South Africa
facility: 205.452.27014 Boehringer Ingelheim Investigational Site
city: Pretoria
country: South Africa
facility: 205.452.27005 Boehringer Ingelheim Investigational Site
city: Pretoria
country: South Africa
facility: 205.452.27009 Boehringer Ingelheim Investigational Site
city: Somerset West
country: South Africa
facility: 205.452.27007 Boehringer Ingelheim Investigational Site
city: Badajoz
country: Spain
facility: 205.452.34018 Boehringer Ingelheim Investigational Site
city: Badalona (Barcelona)
country: Spain
facility: 205.452.34021 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 205.452.34010 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 205.452.34025 Boehringer Ingelheim Investigational Site
city: Centelles
country: Spain
facility: 205.452.34027 Boehringer Ingelheim Investigational Site
city: Cáceres
country: Spain
facility: 205.452.34015 Boehringer Ingelheim Investigational Site
city: Elda
country: Spain
facility: 205.452.34016 Boehringer Ingelheim Investigational Site
city: Hospitalet de Llobregat
country: Spain
facility: 205.452.34008 Boehringer Ingelheim Investigational Site
city: Lugo
country: Spain
facility: 205.452.34026 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 205.452.34011 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 205.452.34019 Boehringer Ingelheim Investigational Site
city: Málaga
country: Spain
facility: 205.452.34020 Boehringer Ingelheim Investigational Site
city: Mérida
country: Spain
facility: 205.452.34002 Boehringer Ingelheim Investigational Site
city: Plasencia
country: Spain
facility: 205.452.34017 Boehringer Ingelheim Investigational Site
city: Pozuelo de Alarcón
country: Spain
facility: 205.452.34001 Boehringer Ingelheim Investigational Site
city: San Juan de Alicante
country: Spain
facility: 205.452.34024 Boehringer Ingelheim Investigational Site
city: Santander
country: Spain
facility: 205.452.34003 Boehringer Ingelheim Investigational Site
city: Terrassa (Barcelona)
country: Spain
facility: 205.452.34005 Boehringer Ingelheim Investigational Site
city: Torrevieja
country: Spain
facility: 205.452.34007 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 205.452.34012 Boehringer Ingelheim Investigational Site
city: Valladolid
country: Spain
facility: 205.452.34013 Boehringer Ingelheim Investigational Site
city: Vic (Barcelona)
country: Spain
facility: 205.452.34009 Boehringer Ingelheim Investigational Site
city: Vilanova i la Geltrú
country: Spain
facility: 205.452.34023 Boehringer Ingelheim Investigational Site
city: Zaragoza
country: Spain
facility: 205.452.34004 Boehringer Ingelheim Investigational Site
city: Brämhult
country: Sweden
facility: 205.452.46005 Boehringer Ingelheim Investigational Site
city: Eksjö
country: Sweden
facility: 205.452.46014 Boehringer Ingelheim Investigational Site
city: Gullspång
country: Sweden
facility: 205.452.46012 Boehringer Ingelheim Investigational Site
city: Göteborg
country: Sweden
facility: 205.452.46013 Boehringer Ingelheim Investigational Site
city: Höllviken
country: Sweden
facility: 205.452.46001 Boehringer Ingelheim Investigational Site
city: Järfälla
country: Sweden
facility: 205.452.46008 Boehringer Ingelheim Investigational Site
city: Kil
country: Sweden
facility: 205.452.46009 Boehringer Ingelheim Investigational Site
city: Lidingö
country: Sweden
facility: 205.452.46007 Boehringer Ingelheim Investigational Site
city: Luleå
country: Sweden
facility: 205.452.46003 Boehringer Ingelheim Investigational Site
city: Sigtuna
country: Sweden
facility: 205.452.46010 Boehringer Ingelheim Investigational Site
city: Solna
country: Sweden
facility: 205.452.46002 Boehringer Ingelheim Investigational Site
city: Uddevalla
country: Sweden
facility: 205.452.46011 Boehringer Ingelheim Investigational Site
city: Örebro
country: Sweden
facility: 205.452.46006 Boehringer Ingelheim Investigational Site
city: Ascona
country: Switzerland
facility: 205.452.41003 Boehringer Ingelheim Investigational Site
city: Basel
country: Switzerland
facility: 205.452.41004 Boehringer Ingelheim Investigational Site
city: Bern
country: Switzerland
facility: 205.452.41016 Boehringer Ingelheim Investigational Site
city: Glarus
country: Switzerland
facility: 205.452.41012 Boehringer Ingelheim Investigational Site
city: Gossau
country: Switzerland
facility: 205.452.41001 Boehringer Ingelheim Investigational Site
city: Liestal
country: Switzerland
facility: 205.452.41015 Boehringer Ingelheim Investigational Site
city: Locarno
country: Switzerland
facility: 205.452.41010 Boehringer Ingelheim Investigational Site
city: Lugano
country: Switzerland
facility: 205.452.41011 Boehringer Ingelheim Investigational Site
city: Spiez
country: Switzerland
facility: 205.452.41007 Boehringer Ingelheim Investigational Site
city: St. Gallen
country: Switzerland
facility: 205.452.41002 Boehringer Ingelheim Investigational Site
city: St. Gallen
country: Switzerland
facility: 205.452.41009 Boehringer Ingelheim Investigational Site
city: Zürich
country: Switzerland
facility: 205.452.41013 Boehringer Ingelheim Investigational Site
city: Zürich
country: Switzerland
facility: 205.452.41014 Boehringer Ingelheim Investigational Site
city: Changhua
country: Taiwan
facility: 205.452.88607 Boehringer Ingelheim Investigational Site
city: Chia-Yi
country: Taiwan
facility: 205.452.88614 Boehringer Ingelheim Investigational Site
city: Kaohsiung City
country: Taiwan
facility: 205.452.88608 Boehringer Ingelheim Investigational Site
city: Kaohsiung City
country: Taiwan
facility: 205.452.88609 Boehringer Ingelheim Investigational Site
city: Kaohsiung
country: Taiwan
facility: 205.452.88611 Boehringer Ingelheim Investigational Site
city: New Taipei
country: Taiwan
facility: 205.452.88604 Boehringer Ingelheim Investigational Site
city: Taichung
country: Taiwan
facility: 205.452.88605 Boehringer Ingelheim Investigational Site
city: Taichung
country: Taiwan
facility: 205.452.88606 Boehringer Ingelheim Investigational Site
city: Taichung
country: Taiwan
facility: 205.452.88612 Boehringer Ingelheim Investigational Site
city: Tainan
country: Taiwan
facility: 205.452.88610 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 205.452.88602 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 205.452.88603 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 205.452.88613 Boehringer Ingelheim Investigational Site
city: Taoyuan County
country: Taiwan
facility: 205.452.88601 Boehringer Ingelheim Investigational Site
city: Chiang Mai
country: Thailand
facility: 205.452.66004 Boehringer Ingelheim Investigational Site
city: Hatyai, Songkhla
country: Thailand
facility: 205.452.66003 Boehringer Ingelheim Investigational Site
city: Khon Kaen
country: Thailand
facility: 205.452.66002 Boehringer Ingelheim Investigational Site
city: Muang, Phitsanulok
country: Thailand
facility: 205.452.66005 Boehringer Ingelheim Investigational Site
city: Nonthaburi
country: Thailand
facility: 205.452.66001 Boehringer Ingelheim Investigational Site
city: Ariana
country: Tunisia
facility: 205.452.21603 Boehringer Ingelheim Investigational Site
city: Ariana
country: Tunisia
facility: 205.452.21605 Boehringer Ingelheim Investigational Site
city: Ariana
country: Tunisia
facility: 205.452.21606 Boehringer Ingelheim Investigational Site
city: Ariana
country: Tunisia
facility: 205.452.21607 Boehringer Ingelheim Investigational Site
city: Mahdia
country: Tunisia
facility: 205.452.21610 Boehringer Ingelheim Investigational Site
city: Monastir
country: Tunisia
facility: 205.452.21609 Boehringer Ingelheim Investigational Site
city: Nabeul
country: Tunisia
facility: 205.452.21608 Boehringer Ingelheim Investigational Site
city: Tunis
country: Tunisia
facility: 205.452.21601 Boehringer Ingelheim Investigational Site
city: Tunis
country: Tunisia
facility: 205.452.21602 Boehringer Ingelheim Investigational Site
city: Tunis
country: Tunisia
facility: 205.452.21604 Boehringer Ingelheim Investigational Site
city: Adana
country: Turkey
facility: 205.452.90001 Boehringer Ingelheim Investigational Site
city: Ankara
country: Turkey
facility: 205.452.90008 Boehringer Ingelheim Investigational Site
city: Ankara
country: Turkey
facility: 205.452.90013 Boehringer Ingelheim Investigational Site
city: Antalya
country: Turkey
facility: 205.452.90005 Boehringer Ingelheim Investigational Site
city: Aydin
country: Turkey
facility: 205.452.90018 Boehringer Ingelheim Investigational Site
city: Bolu
country: Turkey
facility: 205.452.90003 Boehringer Ingelheim Investigational Site
city: Edirne
country: Turkey
facility: 205.452.90006 Boehringer Ingelheim Investigational Site
city: Erzurum
country: Turkey
facility: 205.452.90010 Boehringer Ingelheim Investigational Site
city: Hatay
country: Turkey
facility: 205.452.90019 Boehringer Ingelheim Investigational Site
city: Istanbul
country: Turkey
facility: 205.452.90017 Boehringer Ingelheim Investigational Site
city: Istanbul
country: Turkey
facility: 205.452.90020 Boehringer Ingelheim Investigational Site
city: Istanbul
country: Turkey
facility: 205.452.90021 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 205.452.90015 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 205.452.90016 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 205.452.90022 Boehringer Ingelheim Investigational Site
city: Malatya
country: Turkey
facility: 205.452.90007 Boehringer Ingelheim Investigational Site
city: Crimea
country: Ukraine
facility: 205.452.38028 Boehringer Ingelheim Investigational Site
city: Dnipropetrovks
country: Ukraine
facility: 205.452.38024 Boehringer Ingelheim Investigational Site
city: Dnipropetrovsk
country: Ukraine
facility: 205.452.38022 Boehringer Ingelheim Investigational Site
city: Dnyepropyetrovsk
country: Ukraine
facility: 205.452.38034 Boehringer Ingelheim Investigational Site
city: Donetsk
country: Ukraine
facility: 205.452.38002 Boehringer Ingelheim Investigational Site
city: Donetsk
country: Ukraine
facility: 205.452.38020 Boehringer Ingelheim Investigational Site
city: Ivano-Frankivsk
country: Ukraine
facility: 205.452.38011 Boehringer Ingelheim Investigational Site
city: Kharkiv
country: Ukraine
facility: 205.452.38005 Boehringer Ingelheim Investigational Site
city: Kharkov
country: Ukraine
facility: 205.452.38001 Boehringer Ingelheim Investigational Site
city: Kharkov
country: Ukraine
facility: 205.452.38004 Boehringer Ingelheim Investigational Site
city: Kharkov
country: Ukraine
facility: 205.452.38006 Boehringer Ingelheim Investigational Site
city: Kharkov
country: Ukraine
facility: 205.452.38008 Boehringer Ingelheim Investigational Site
city: Kharkov
country: Ukraine
facility: 205.452.38018 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 205.452.38003 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 205.452.38010 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 205.452.38012 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 205.452.38013 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 205.452.38015 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 205.452.38032 Boehringer Ingelheim Investigational Site
city: Nikolayev
country: Ukraine
facility: 205.452.38026 Boehringer Ingelheim Investigational Site
city: Odesa
country: Ukraine
facility: 205.452.38023 Boehringer Ingelheim Investigational Site
city: Odessa
country: Ukraine
facility: 205.452.38027 Boehringer Ingelheim Investigational Site
city: Odessa
country: Ukraine
facility: 205.452.38031 Boehringer Ingelheim Investigational Site
city: Simferopol
country: Ukraine
facility: 205.452.38017 Boehringer Ingelheim Investigational Site
city: Vinnytsya
country: Ukraine
facility: 205.452.38019 Boehringer Ingelheim Investigational Site
city: Zaporizhzhya
country: Ukraine
facility: 205.452.38030 Boehringer Ingelheim Investigational Site
city: Atherstone
country: United Kingdom
facility: 205.452.44010 Boehringer Ingelheim Investigational Site
city: Burbage
country: United Kingdom
facility: 205.452.44008 Boehringer Ingelheim Investigational Site
city: Chertsey
country: United Kingdom
facility: 205.452.44004 Boehringer Ingelheim Investigational Site
city: Chesterfield
country: United Kingdom
facility: 205.452.44002 Boehringer Ingelheim Investigational Site
city: Coventry
country: United Kingdom
facility: 205.452.44003 Boehringer Ingelheim Investigational Site
city: Exeter
country: United Kingdom
facility: 205.452.44001 Boehringer Ingelheim Investigational Site
city: Fowey
country: United Kingdom
facility: 205.452.44007 Boehringer Ingelheim Investigational Site
city: Frome
country: United Kingdom
facility: 205.452.44005 Boehringer Ingelheim Investigational Site
city: Leamington Spa
country: United Kingdom
facility: 205.452.44011 Boehringer Ingelheim Investigational Site
city: St Just, Penzance
country: United Kingdom
facility: 205.452.44006 Boehringer Ingelheim Investigational Site
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References:
citation: Wise RA, Calverley PM, Carter K, Clerisme-Beaty E, Metzdorf N, Anzueto A. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(R) trial. Int J Chron Obstruct Pulmon Dis. 2018 Feb 14;13:605-616. doi: 10.2147/COPD.S148393. eCollection 2018.
citation: Calverley PMA, Mueller A, Fowler A, Metzdorf N, Wise RA. The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV1/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants. Ann Am Thorac Soc. 2018 Feb;15(2):200-208. doi: 10.1513/AnnalsATS.201703-194OC.
citation: Dahl R, Calverley PM, Anzueto A, Metzdorf N, Fowler A, Mueller A, Wise R, Dusser D. Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial. BMJ Open. 2015 Dec 29;5(12):e009015. doi: 10.1136/bmjopen-2015-009015.
citation: Anzueto A, Wise R, Calverley P, Dusser D, Tang W, Metzdorf N, Dahl R. The Tiotropium Safety and Performance in Respimat(R) (TIOSPIR(R)) Trial: Spirometry Outcomes. Respir Res. 2015 Sep 15;16(1):107. doi: 10.1186/s12931-015-0269-4.
citation: Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators. Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.